SLR Investment (SLRC) 10-Q 2017 Q1 Quarterly report

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Quarter Ended March 31, 2017

☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Commission File Number: 814-00754

SOLAR CAPITAL LTD.

(Exact name of registrant as specified in its charter)

Maryland	26-1381340
(State of Incorporation)	(I.R.S. Employer Identification No.)
500 Park Avenue New York, N.Y.	10022
(Address of principal executive offices)	(Zip Code)

(212) 993-1670

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 ofRegulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ☐    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller Reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  ☒

The number of shares of the registrant’s Common Stock, $.01 par value, outstanding as of May 1, 2017 was 42,260,826.

SOLAR CAPITAL LTD.

FORM 10-Q FOR THE QUARTER ENDED MARCH 31, 2017

TABLE OF CONTENTS

		PAGE
PART I. FINANCIAL INFORMATION
Item 1.	Financial Statements Consolidated Statements of Assets and Liabilities as of March 31, 2017 (unaudited) and December 31, 2016		3
	Consolidated Statements of Operations for the three months ended March 31, 2017 (unaudited) and the three months ended March 31, 2016 (unaudited)		4
	Consolidated Statements of Changes in Net Assets for the three months ended March 31, 2017 (unaudited) and the year ended December 31, 2016		5
	Consolidated Statements of Cash Flows for the three months ended March 31, 2017 (unaudited) and the three months ended March 31, 2016 (unaudited)		6
	Consolidated Schedule of Investments as of March 31, 2017 (unaudited)		7
	Consolidated Schedule of Investments as of December 31, 2016		10
	Notes to Consolidated Financial Statements (unaudited)		13
	Report of Independent Registered Public Accounting Firm		38
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		39
Item 3.	Quantitative and Qualitative Disclosures About Market Risk		61
Item 4.	Controls and Procedures		61
PART II. OTHER INFORMATION
Item 1.	Legal Proceedings		63
Item 1A.	Risk Factors		63
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		63
Item 3.	Defaults Upon Senior Securities		63
Item 4.	Mine Safety Disclosures		63
Item 5.	Other Information		63
Item 6.	Exhibits		64
	Signatures		66

PART I. FINANCIAL INFORMATION

In this Quarterly Report, “Solar Capital”, “Company”, “Fund”, “we”, “us”, and “our” refer to Solar Capital Ltd. unless the context states otherwise.

Item 1. Financial Statements

SOLAR CAPITAL LTD.

CONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES

(in thousands, except share amounts)

	March 31, 2017 (unaudited)			December 31, 2016
Assets
Investments at fair value:
Companies less than 5% owned (cost: $835,590 and $815,955, respectively)	$	825,238		$	804,783
Companies 5% to 25% owned (cost: $8,511 and $8,511, respectively)		—			777
Companies more than 25% owned (cost: $476,317 and $477,491, respectively)		498,257			499,218
Total investments (cost: $1,320,418 and $1,301,957, respectively)		1,323,495			1,304,778
Cash		24,132			2,152
Cash equivalents (cost: $399,808 and $309,894, respectively)		399,808			309,894
Receivable for investments sold		17,526			13,602
Interest receivable		5,898			8,079
Dividends receivable		11,594			10,952
Other receivable		55			54
Prepaid expenses and other assets		1,404			1,036
Total assets	$	1,783,912		$	1,650,547
Liabilities
Revolving credit facilities (see notes 6 and 8)	$	—		$	115,200
Unsecured senior notes due 2022 (see notes 6 and 8)		150,000			50,000
Unsecured senior notes due 2042 ($100,000 and $100,000 face amounts, respectively, reported net of unamortized debt issuance costs of $2,859 and $2,886, respectively. See note 8)		97,141			97,114
Senior secured notes (see notes 6 and 8)		75,000			75,000
Term loan (see notes 6 and 8)		50,000			50,000
Distributions payable		16,899			16,899
Payable for investments and cash equivalents purchased		459,980			309,894
Management fee payable (see note 3)		6,719			6,870
Performance-based incentive fee payable (see note 3)		4,083			4,412
Interest payable (see note 8)		4,059			2,225
Administrative services expense payable (see note 3)		437			3,289
Other liabilities and accrued expenses		828			1,137
Total liabilities	$	865,146		$	732,040
Commitments and contingencies (see notes 12, 13 & 14)
Net Assets
Common stock, par value $0.01 per share, 200,000,000 and 200,000,000 common shares authorized, respectively, and 42,248,525 and 42,248,525 shares issued and outstanding, respectively	$	422		$	422
Paid-in capital in excess of par		989,732			989,732
Distributions in excess of net investment income		(12,416	)		(11,847	)
Accumulated net realized loss		(62,049	)		(62,621	)
Net unrealized appreciation		3,077			2,821
Total net assets	$	918,766		$	918,507
Net Asset Value Per Share	$	21.75		$	21.74

See notes to consolidated financial statements.

3

SOLAR CAPITAL LTD.

CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)

(in thousands, except share amounts)

	Three months ended
	March 31, 2017			March 31, 2016
INVESTMENT INCOME:
Interest:
Companies less than 5% owned	$	21,818		$	23,597
Companies more than 25% owned		334			531
Dividends:
Companies less than 5% owned		10			—
Companies more than 25% owned		11,678			9,886
Other income:
Companies less than 5% owned		492			—
Companies more than 25% owned		60			19
Total investment income		34,392			34,033
EXPENSES:
Management fees (see note 3)	$	6,719		$	6,748
Performance-based incentive fees (see note 3)		4,083			4,030
Interest and other credit facility expenses (see note 8)		5,669			5,021
Administrative services expense (see note 3)		1,335			1,319
Other general and administrative expenses		256			795
Total expenses		18,062			17,913
Performance-based incentive fees waived (see note 3)		—			(795	)
Net expenses		18,062			17,118
Net investment income	$	16,330		$	16,915
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS, CASH EQUIVALENTS AND FOREIGN CURRENCIES:
Net realized gain (loss) on investments and cash equivalents:
Companies less than 5% owned	$	588		$	—
Companies 5% to 25% owned		(15	)		—
Net realized gain on investments and cash equivalents		573			—
Net realized gain (loss) on foreign currencies		(1	)		1
Net realized gain		572			1
Net change in unrealized gain (loss) on investments and cash equivalents		256			11,260
Net change in unrealized gain (loss) on foreign currencies		—			1
Net change in unrealized gain (loss)		256			11,261
Net realized and unrealized gain (loss) on investments, cash equivalents and foreign currencies		828			11,262
NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS	$	17,158		$	28,177
EARNINGS PER SHARE (see note 5)	$	0.41		$	0.67

See notes to consolidated financial statements.

4

SOLAR CAPITAL LTD.

CONSOLIDATED STATEMENTS OF CHANGES IN NET ASSETS

(in thousands, except share amounts)

	Three months ended March 31, 2017 (unaudited)			Year ended December 31, 2016
Increase in net assets resulting from operations:
Net investment income	$	16,330		$	71,101
Net realized gain		572			776
Net change in unrealized gain		256			34,938
Net increase in net assets resulting from operations		17,158			106,815
Distributions to stockholders:
From net investment income		(16,899	)		(67,598	)
Capital transactions (see note 16):
Repurchases of common stock		—			(3,408	)
Net decrease in net assets resulting from capital transactions		—			(3,408	)
Total increase in net assets		259			35,809
Net assets at beginning of period		918,507			882,698
Net assets at end of period(1)	$	918,766		$	918,507
Capital stock activity:
Common stock repurchased		—			(216,237	)
Net decrease from capital stock activity		—			(216,237	)

(1) Includes overdistributed net investment income of ($12,416) and ($11,847), respectively.

See notes to consolidated financial statements.

5

SOLAR CAPITAL LTD.

CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)

(in thousands)

	Three months ended
	March 31, 2017			March 31, 2016
Cash Flows from Operating Activities:
Net increase in net assets resulting from operations	$	17,158		$	28,177
Adjustments to reconcile net increase in net assets resulting from operations to net cash provided by (used in) operating activities:
Net realized (gain) loss on investments and cash equivalents		(573	)		—
Net realized (gain) loss on foreign currencies		1			(1	)
Net change in unrealized (gain) loss on investments and cash equivalents		(256	)		(11,260	)
Net change in unrealized gain on foreign currencies		—			(1	)
(Increase) decrease in operating assets:
Purchase of investments		(101,369	)		(43,861	)
Proceeds from disposition of investments		83,347			29,862
Capitalization of payment-in-kind interest		(40	)		—
Collections of payment-in-kind interest		173			—
Receivable for investments sold		(3,924	)		533
Interest receivable		2,181			(1,760	)
Dividends receivable		(642	)		(1,271	)
Other receivable		(1	)		(11	)
Prepaid expenses and other assets		(368	)		(444	)
Increase (decrease) in operating liabilities:
Payable for investments and cash equivalents purchased		150,086			(2,534	)
Management fee payable		(151	)		225
Performance-based incentive fee payable		(329	)		1,827
Administrative services expense payable		(2,852	)		(2,090	)
Interest payable		1,834			1,428
Other liabilities and accrued expenses		(309	)		164
Net Cash Provided by (Used in) Operating Activities		143,966			(1,017	)
Cash Flows from Financing Activities:
Cash distributions paid		(16,899	)		(16,986	)
Proceeds from issuance of unsecured debt		100,000			—
Deferred financing costs		27			28
Repurchase of common stock		—			(3,408	)
Proceeds from secured borrowings		97,500			114,000
Repayment of secured borrowings		(212,700	)		(99,500	)
Net Cash Used in Financing Activities		(32,072	)		(5,866	)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		111,894			(6,883	)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD		312,046			277,570
CASH AND CASH EQUIVALENTS AT END OF PERIOD	$	423,940		$	270,687
Supplemental disclosure of cash flow information:
Cash paid for interest	$	3,835		$	3,593

See notes to consolidated financial statements.

6

SOLAR CAPITAL LTD.

CONSOLIDATED SCHEDULE OF INVESTMENTS (unaudited)

March 31, 2017

(in thousands, except share/unit amounts)

Description	Industry	Spread Above Index(10)		LIBOR Floor		Interest Rate(1)		Acquisition Date	Maturity Date		Par Amount		Cost		Fair Value
Bank Debt/Senior Secured Loans — 87.8%
AccentCare, Inc	Health Care Providers & Services	L+950		1.00	%	10.50	%	9/3/2015	9/3/2022	$	10,000	$	9,854	$	9,725
Achaogen, Inc.(6)	Pharmaceuticals	L+699		1.00	%	7.99	%	8/5/2015	8/5/2019		25,000		25,433		25,925
Aegis Toxicology Sciences Corporation	Health Care Providers & Services	L+850		1.00	%	9.66	%	2/20/2014	8/24/2021		31,000		30,543		27,900
AgaMatrix, Inc	Health Care Equipment & Supplies	L+835		—		9.13	%	2/6/2015	2/1/2019		7,667		7,760		7,782
AirXpanders, Inc.	Health Care Equipment & Supplies	—		—		7.34	%	4/22/2016	7/14/2017		625		673		663
American Teleconferencing Services, Ltd. (PGI)	Communications Equipment	L+650		1.00	%	7.50	%	5/5/2016	12/8/2021		22,518		21,865		22,406
Amerilife Group, LLC	Insurance	L+875		1.00	%	9.75	%	7/9/2015	1/10/2023		15,000		14,750		14,700
Argo Turboserve Corporation & Argo Tech, LLC††	Air Freight & Logistics	L+1225	(11)	—		13.31	%	5/2/2014	5/2/2018		12,077		11,985		11,987
aTyr Pharma, Inc	Pharmaceuticals	P+410		—		7.85	%	11/18/2016	11/18/2020		5,000		4,929		4,950
AviatorCap SII, LLC I(3)	Aerospace & Defense	—		—		12.00	%	5/31/2011	1/31/2019		383		383		383
Axcella Health Inc	Pharmaceuticals	L+880		—		9.58	%	8/7/2015	8/31/2019		20,000		20,361		20,350
Bishop Lifting Products, Inc.(8)	Trading Companies & Distributors	L+800		1.00	%	9.00	%	3/24/2014	3/27/2022		25,000		24,834		21,000
Breathe Technologies, Inc	Health Care Equipment & Supplies	L+830		—		9.08	%	11/5/2015	11/5/2019		15,000		15,145		13,500
CardioDx, Inc	Health Care Providers & Services	P+670		—		10.70	%	6/18/2015	4/1/2019		6,250		6,550		6,250
CardioFocus, Inc	Health Care Equipment & Supplies	L+750		—		8.48	%	3/31/2017	7/1/2020		4,300		4,237		4,237
Cardiva Medical, Inc	Health Care Equipment & Supplies	L+865		—		9.43	%	2/2/2017	2/2/2021		6,000		6,021		6,000
CAS Medical Systems, Inc	Health Care Equipment & Supplies	L+875		—		9.53	%	6/30/2016	7/1/2020		6,000		6,022		6,000
Cianna Medical, Inc	Health Care Equipment & Supplies	L+900		—		9.78	%	9/28/2016	9/28/2020		6,000		6,012		6,000
Clinical Ink, Inc	Health Care Technology	L+850		0.70	%	9.28	%	3/8/2016	3/8/2020		6,500		6,507		6,435
Conventus Orthopaedics, Inc	Health Care Equipment & Supplies	L+865		—		9.46	%	6/15/2016	6/1/2020		5,250		5,205		5,092
Datapipe, Inc	IT Services	L+800		1.00	%	9.00	%	8/14/2014	9/15/2019		27,000		26,659		26,932
Direct Buy Inc.(4)**††	Multiline Retail	—		—		12.00% PI	K	11/5/2012	10/31/2019		11,439		8,511		—
DISA Holdings Acquisition Subsidiary Corp	Professional Services	L+850		1.00	%	9.50	%	12/9/2014	6/9/2021		51,476		50,925		50,961
Easyfinancial Services, Inc.(5)(6)	Consumer Finance	BA+699		1.00	%	7.99	%	9/27/2012	10/4/2019	C$	10,000		9,261		7,491
Entegrion, Inc	Health Care Equipment & Supplies	—		—		10.03	%	4/22/2016	4/1/2017	$	100		128		104
Falmouth Group Holdings Corp. (AMPAC)	Chemicals	L+675		1.00	%	7.75	%	12/7/2015	12/14/2021		10,139		10,091		10,139
Global Holdings LLC & Payment Concepts LLC	Consumer Finance	L+650		1.00	%	7.50	%	3/31/2017	5/3/2022		17,500		17,150		17,150
Global Tel*Link Corporation	Communications Equipment	L+375		1.25	%	5.00	%	11/6/2015	5/23/2020		7,307		6,043		7,306
Global Tel*Link Corporation	Communications Equipment	L+775		1.25	%	9.00	%	5/21/2013	11/23/2020		18,500		18,278		18,454
Greystone Select Holdings LLC & Greystone & Co., Inc.	Thrifts & Mortgage Finance	L+800		1.00	%	9.00	%	3/29/2017	4/17/2024		20,000		19,800		19,800
IHS Intermediate, Inc	Health Care Providers & Services	L+825		1.00	%	9.25	%	6/19/2015	7/20/2022		25,000		24,593		24,125
Inmar Acquisition Sub, Inc	Professional Services	L+700		1.00	%	8.15	%	1/27/2014	1/27/2022		10,000		9,932		10,000
Island Medical Management Holdings, LLC	Health Care Providers & Services	L+550		1.00	%	6.50	%	3/31/2017	9/1/2022		4,638		4,592		4,592
K2 Pure Solutions NoCal, L.P	Chemicals	L+900		1.00	%	10.00	%	8/19/2013	2/19/2021		7,475		7,383		7,251
Kore Wireless Group, Inc	Wireless Telecommunication Services	L+825		1.00	%	9.25	%	9/12/2014	3/12/2021		55,500		54,742		55,084
Lumeris Solutions Company, LLC	Health Care Technology	L+860		0.25	%	9.58	%	3/22/2017	2/1/2020		16,000		15,882		15,873
Mitralign, Inc	Health Care Equipment & Supplies	—		—		9.48	%	4/22/2016	12/1/2018		1,458		1,416		1,451
Nabsys 2.0 LLC	Life Sciences Tools & Services	—		—		8.90	%	4/22/2016	10/13/2018		4,373		4,395		4,439
PhyMed Management LLC	Health Care Providers & Services	L+875		1.00	%	9.75	%	12/18/2015	5/18/2021		32,321		31,272		31,190
PQ Bypass, Inc.	Health Care Equipment & Supplies	L+885		—		9.63	%	4/21/2016	4/21/2020		5,000		4,952		4,975
Rapid Micro Biosystems, Inc.	Life Sciences Tools & Services	L+880		—		9.58	%	6/30/2015	6/30/2019		16,000		16,401		15,760
Rug Doctor LLC(3)	Diversified Consumer Services	L+975		1.50	%	11.25	%	12/23/2013	12/31/2018		9,111		8,950		9,111
Salient Partners, L.P	Asset Management	L+850		1.00	%	9.52	%	6/10/2015	6/9/2021		14,580		14,361		14,361
Scynexis, Inc	Pharmaceuticals	L+849		—		9.30	%	9/30/2016	9/30/2020		15,000		14,865		14,850
SentreHeart, Inc	Health Care Equipment & Supplies	L+885		—		9.63	%	11/15/2016	11/15/2020		10,000		9,824		9,799
SOINT, LLC(3)	Aerospace & Defense	—		—		15.00	%	6/8/2012	11/30/2018		820		818		820
Southern Auto Finance Company(6)	Consumer Finance	—		—		11.50	%	10/19/2011	12/4/2018		25,000		24,836		24,500
Sunesis Pharmaceuticals, Inc.	Pharmaceuticals	L+854		—		9.35	%	3/31/2016	4/1/2020		7,500		7,425		7,481
TierPoint, LLC	IT Services	L+875-887.5		1.00	%	9.75-9.88	%	12/2/2014	12/2/2022		34,000		33,669		34,000
TMK Hawk Parent, Corp. (TriMark)	Trading Companies and Distributors	L+750		1.00	%	8.50	%	9/26/2014	10/1/2022		20,000		19,848		20,000
TouchTunes Interactive Networks, Inc	Media	L+825		1.00	%	9.35	%	5/28/2015	5/27/2022		14,000		13,832		13,825
Trevi Therapeutics, Inc	Pharmaceuticals	L+775		—		8.53	%	12/29/2014	6/29/2018		5,500		5,737		5,555
U.S. Anesthesia Partners Inc.	Health Care Providers & Services	L+925		1.00	%	10.25	%	9/24/2014	9/24/2020		30,000		29,806		29,775
Vapotherm, Inc	Health Care Equipment & Supplies	L+899		—		9.77	%	11/16/2016	5/16/2021		20,000		19,855		19,800
Varilease Finance, Inc	Multi-Sector Holdings	L+825		1.00	%	9.25	%	8/22/2014	8/24/2020		48,000		47,439		48,000
Total Bank Debt/Senior Secured Loans												$	822,740	$	806,239
Subordinated Debt/Corporate Notes — 3.1%
Alegeus Technologies Holdings Corp	Health Care Technology	L+1200		1.00	%	13.00	%	6/24/2012	2/15/2019	$	28,200	$	27,965	$	28,200
										Shares/Units
Preferred Equity — 1.6%
SOAGG LLC(3)(6)(7)	Aerospace & Defense	—		—		8.00	%	12/14/2010	6/30/2018		5,295	$	5,295	$	5,571
SOINT, LLC(3)(6)(7)	Aerospace & Defense	—		—		15.00	%	6/8/2012	6/30/2018		86,667		8,667		9,100
Total Preferred Equity												$	13,962	$	14,671

See notes to consolidated financial statements.

7

SOLAR CAPITAL LTD.

CONSOLIDATED SCHEDULE OF INVESTMENTS (unaudited) (continued)

March 31, 2017

(in thousands, except share/unit amounts)

Description	Industry	Acquisition Date	Maturity Date		Shares/ Units		Cost		Fair Value
Common Equity/Equity Interests/Warrants — 51.6%
Ark Real Estate Partners LP(2)(3)*	Diversified Real Estate Activities	3/12/2007			—	$	527	$	336
Ark Real Estate Partners II LP(2)(3)*	Diversified Real Estate Activities	10/23/2012			—		12		8
aTyr Pharma, Inc. Warrants*	Pharmaceuticals	11/18/2016			47,771		70		50
B Riley Financial Inc.(6)	Research & Consulting Services	3/16/2007			38,015		2,684		570
CardioDx, Inc. Warrants*	Health Care Providers & Services	6/18/2015			39,863		129		—
CardoFocus, Inc. Warrants*	Health Care Equipment & Supplies	3/31/2017			357,643		42		42
CAS Medical Systems, Inc. Warrants*	Health Care Equipment & Supplies	6/30/2016			48,491		38		14
Cianna Medical, Inc. Warrants*	Health Care Equipment & Supplies	9/28/2016			89,726		37		38
Conventus Orthopaedics, Inc. Warrants*	Health Care Equipment & Supplies	6/15/2016			157,500		65		49
Crystal Financial LLC(3)(6)	Diversified Financial Services	12/28/2012			280,303		280,737		305,700
Direct Buy Inc.(4)*	Multiline Retail	11/5/2012			76,999		—		—
Essence Group Holdings Corporation (Lumeris) Warrants*.	Health Care Technology	3/22/2017			208,000		63		56
PQ Bypass, Inc. Warrants*	Health Care Equipment & Supplies	4/21/2016			176,471		70		46
RD Holdco Inc. (Rug Doctor)(3)*	Diversified Consumer Services	12/23/2013			231,177		15,683		12,566
RD Holdco Inc. (Rug Doctor) Class B(3)*	Diversified Consumer Services	12/23/2013			522		5,216		5,216
RD Holdco Inc. (Rug Doctor) Warrants(3)*	Diversified Consumer Services	12/23/2013			30,370		381		121
Scynexis, Inc. Warrants*	Pharmaceuticals	9/30/2016			122,435		105		27
Senior Secured Unitranche Loan Program LLC(3)(6)	Asset Management	11/25/2015			—		101,878		100,781
Senior Secured Unitranche Loan Program II LLC(3)(6)	Asset Management	8/5/2016			—		47,770		48,544
SentreHeart, Inc. Warrants*	Health Care Equipment & Supplies	11/15/2016			261,825		126		95
Sunesis Pharmaceuticals, Inc. Warrants*	Pharmaceuticals	3/31/2016			104,001		118		126
Total Common Equity/Equity Interests/Warrants						$	455,751	$	474,385
Total Investments(9) — 144.1%						$	1,320,418	$	1,323,495
				Par Amount
Cash Equivalents — 43.5%
U.S. Treasury Bill	Government	3/30/2017	4/27/2017	$	400,000	$	399,808	$	399,808
Total Investments & Cash Equivalents — 187.6%						$	1,720,226	$	1,723,303
Liabilities in Excess of Other Assets — (87.6%)									(804,537	)
Net Assets — 100.0%								$	918,766

(1) Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of March 31, 2017.

(2) Ark Real Estate Partners is held through SLRC ADI Corp., a taxable subsidiary.

(3) Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940 (“1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the three months ended March 31, 2017 in these controlled investments are as follows:

Name of Issuer	Fair Value at December 31, 2016		Gross Additions		Gross Reductions		Realized Gain (Loss)		Interest/ Dividend/ Other Income		Fair Value at March 31, 2017
ARK Real Estate Partners LP	$	336	$	—	$	—	$	—	$	—	$	336
ARK Real Estate Partners II LP		8		—		—		—		—		8
AviatorCap SII, LLC I		497		—		114		—		13		383
Crystal Financial LLC		305,000		—		—		—		7,900		305,700
RD Holdco Inc. (Rug Doctor, common equity).		13,574		—		—		—		—		12,566
RD Holdco Inc. (Rug Doctor, class B)		5,216		—		—		—		—		5,216
RD Holdco Inc. (Rug Doctor, warrants)		168		—		—		—		—		121
Rug Doctor LLC		9,111		—		—		—		284		9,111
Senior Secured Unitranche Loan Program LLC		100,653		—		—		—		2,181		100,781
Senior Secured Unitranche Loan Program II LLC		47,363		807		—		—		1,224		48,544
SOAGG LLC		5,806		—		327		—		108		5,571
SOINT, LLC		2,386		—		1,567		—		42		820
SOINT, LLC (preferred equity)		9,100		—		—		—		320		9,100
	$	499,218	$	807	$	2,008	$	—	$	12,072	$	498,257

(4) Denotes investments in which we are an “Affiliated Person” but not exercising a controlling influence, as defined in the 1940 Act, due to beneficially owning, either directly or through one or more controlled companies, more than 5% but less than 25% of the outstanding voting securities of the investment. Transactions during the three months ended March 31, 2017 in these affiliated investments are as follows:

Name of Issuer	Fair Value at December 31, 2016		Gross Additions		Gross Reductions		Realized Gain (Loss)			Interest/ Dividend Income		Fair Value at March 31, 2017
Direct Buy Inc. (common equity)	$	—	$	—	$	—	$	—		$	—	$	—
Direct Buy Inc. (senior secured loan)		777		333		—		—			—		—
DSW Group Holdings LLC		—		—		—		(15	)†		—		—
								��
	$	777	$	333	$	—	$	(15	)	$	—	$	—

See notes to consolidated financial statements.

8

SOLAR CAPITAL LTD.

CONSOLIDATED SCHEDULE OF INVESTMENTS (unaudited) (continued)

March 31, 2017

(in thousands)

(5) The following entity is domiciled outside the United States and the investments are denominated in Canadian Dollars: Easyfinancial Services, Inc. in Canada.

(6) Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the Investment Company Act of 1940 (“1940 Act”), as amended. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of March 31, 2017, on a fair value basis, non-qualifying assets in the portfolio represented 29.3% of the total assets of the Company.

(7) Solar Capital Ltd.’s investments in SOAGG, LLC and SOINT, LLC include a two and one dollar investment in common shares, respectively.

(8) Bishop Lifting Products, Inc., SEI Holding I Corporation, Singer Equities, Inc. & Hampton Rubber Company are co-borrowers.

(9) Aggregate net unrealized depreciation for U.S. federal income tax purposes is $5,094; aggregate gross unrealized appreciation and depreciation for federal tax purposes is $28,311 and $33,405, respectively, based on a tax cost of $1,328,589. All of the Company’s investments are pledged as collateral against the borrowings outstanding on the revolving credit facilities.

(10) Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or PRIME rate. These instruments are typically subject to a LIBOR or PRIME rate floor.

(11) Spread is 10.25% Cash / 2.00% PIK.

* Non-income producing security.

** Investment is on non-accrual status.

† Represents estimated change in receivable balance.

†† Investment contains a payment-in-kind (“PIK”) feature.

Industry Classification	Percentage of Total Investments (at fair value) as of March 31, 2017
Diversified Financial Services		23.1	%
Asset Management		12.4	%
Health Care Providers & Services		10.1	%
Health Care Equipment & Supplies		6.5	%
Pharmaceuticals		6.0	%
Professional Services		4.6	%
IT Services		4.6	%
Wireless Telecommunication Services		4.2	%
Health Care Technology		3.8	%
Consumer Finance		3.7	%
Communications Equipment		3.6	%
Multi-Sector Holdings		3.6	%
Trading Companies & Distributors		3.1	%
Diversified Consumer Services		2.1	%
Life Sciences Tools & Services		1.5	%
Thrifts & Mortgage Finance		1.5	%
Chemicals		1.3	%
Aerospace & Defense		1.2	%
Insurance		1.1	%
Media		1.0	%
Air Freight & Logistics		0.9	%
Research & Consulting Services		0.1	%
Diversified Real Estate Activities		0.0	%
Total Investments		100.0	%

See notes to consolidated financial statements.

9

SOLAR CAPITAL LTD.

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2016

(in thousands, except share/unit amounts)

Description	Industry	Spread Above Index(10)	LIBOR Floor		Interest Rate(1)		Acquisition Date	Maturity Date		Par Amount		Cost		Fair Value
Bank Debt/Senior Secured Loans — 85.8%
AccentCare, Inc	Health Care Providers & Services	L+950	1.00	%	10.50	%	9/3/2015	9/3/2022	$	17,500	$	17,235	$	17,369
Achaogen, Inc.(6)	Pharmaceuticals	L+699	1.00	%	7.99	%	8/5/2015	8/5/2019		25,000		25,297		25,625
Aegis Toxicology Sciences Corporation	Health Care Providers & Services	L+850	1.00	%	9.50	%	2/20/2014	8/24/2021		29,000		28,731		27,115
AgaMatrix, Inc	Health Care Equipment & Supplies	L+835	—		9.00	%	2/6/2015	2/1/2019		8,667		8,708		8,753
AirXpanders, Inc.	Health Care Equipment & Supplies	—	—		7.34	%	4/22/2016	7/14/2017		1,000		1,015		1,025
American Teleconferencing Services, Ltd. (PGI)	Communications Equipment	L+650	1.00	%	7.50	%	5/5/2016	12/8/2021		5,591		5,081		5,437
Amerilife Group, LLC	Insurance	L+875	1.00	%	9.75	%	7/9/2015	1/10/2023		15,000		14,742		14,700
Argo Turboserve Corporation & Argo Tech, LLC	Air Freight & Logistics	L+1025	—		11.19	%	5/2/2014	5/2/2018		12,330		12,330		12,206
Asurion, LLC	Insurance	L+750	1.00	%	8.50	%	2/27/2014	3/3/2021		3,360		3,140		3,422
aTyr Pharma, Inc	Pharmaceuticals	P+410	—		7.60	%	11/18/2016	11/18/2020		5,000		4,896		4,880
AviatorCap SII, LLC I(3)	Aerospace & Defense	—	—		12.00	%	5/31/2011	1/31/2019		497		497		497
Axcella Health Inc	Pharmaceuticals	L+880	—		9.41	%	8/7/2015	8/31/2019		20,000		20,151		20,100
Bishop Lifting Products, Inc.(8)	Trading Companies & Distributors	L+800	1.00	%	9.00	%	3/24/2014	3/27/2022		25,000		24,827		20,500
Breathe Technologies, Inc	Health Care Equipment & Supplies	L+830	—		8.91	%	11/5/2015	11/5/2019		15,000		15,089		12,750
CardioDx, Inc	Health Care Providers & Services	P+670	—		10.45	%	6/18/2015	4/1/2019		7,000		7,205		6,860
Cardiva Medical, Inc	Health Care Equipment & Supplies	L+870	—		9.31	%	8/19/2015	8/19/2019		8,500		8,645		8,585
CAS Medical Systems, Inc	Health Care Equipment & Supplies	L+875	—		9.36	%	6/30/2016	7/1/2020		6,000		6,003		6,000
Cerapedics, Inc	Health Care Equipment & Supplies	—	—		8.68- 8.78	%	4/22/2016	3/1/2019		6,394		6,181		6,394
Cianna Medical, Inc	Health Care Equipment & Supplies	L+900	—		9.61	%	9/28/2016	9/28/2020		6,000		5,988		6,000
Clinical Ink, Inc	Health Care Technology	L+850	0.70	%	9.20	%	3/8/2016	3/8/2020		6,500		6,490		6,435
Conventus Orthopaedics, Inc	Health Care Equipment & Supplies	L+865	—		9.28	%	6/15/2016	6/1/2020		5,250		5,182		5,198
Datapipe, Inc	IT Services	L+800	1.00	%	9.00	%	8/14/2014	9/15/2019		27,000		26,629		26,892
Delphinus Medical Technologies, Inc	Health Care Equipment & Supplies	—	—		9.25- 9.30	%	4/22/2016	2/23/2017		400		434		420
Direct Buy Inc.(4)**	Multiline Retail	—	—		12.00% PI	K	11/5/2012	10/31/2019		11,105		8,511		777
DISA Holdings Acquisition Subsidiary Corp	Professional Services	L+850	1.00	%	9.50	%	12/9/2014	6/9/2021		51,476		50,898		50,704
Easyfinancial Services, Inc.(5)(6)	Consumer Finance	BA+699	1.00	%	7.99	%	9/27/2012	10/4/2019	C$	10,000		9,261		7,410
Emerging Markets Communications, LLC	Wireless Telecommunication Services	L+962.5	1.00	%	10.63	%	6/29/2015	7/1/2022	$	27,000		26,658		27,000
Entegrion, Inc	Health Care Equipment & Supplies	—	—		10.03	%	4/22/2016	4/1/2017		400		414		412
Falmouth Group Holdings Corp. (AMPAC)	Chemicals	L+675	1.00	%	7.75	%	12/7/2015	12/14/2021		10,164		10,114		10,164
Global Tel*Link Corporation	Communications Equipment	L+375	1.25	%	5.00	%	11/6/2015	5/23/2020		7,328		5,978		7,310
Global Tel*Link Corporation	Communications Equipment	L+775	1.25	%	9.00	%	5/21/2013	11/23/2020		18,500		18,265		18,012
Greystone Select Holdings LLC & Greystone & Co., Inc.	Thrifts & Mortgage Finance	L+800	1.00	%	9.00	%	3/25/2014	3/26/2021		9,680		9,642		9,559
Hyland Software, Inc	Software	L+725	1.00	%	8.25	%	6/12/2015	6/30/2023		5,000		4,979		5,000
IHS Intermediate, Inc	Health Care Providers & Services	L+825	1.00	%	9.25	%	6/19/2015	7/20/2022		25,000		24,578		24,125
Inmar Acquisition Sub, Inc	Professional Services	L+700	1.00	%	8.00	%	1/27/2014	1/27/2022		10,000		9,929		9,850
K2 Pure Solutions NoCal, L.P	Chemicals	L+900	1.00	%	10.00	%	8/19/2013	2/19/2021		7,475		7,398		7,176
Kore Wireless Group, Inc	Wireless Telecommunication Services	L+825	1.00	%	9.25	%	9/12/2014	3/12/2021		55,500		54,704		54,945
Lumeris Solutions Company, LLC	Health Care Technology	—	—		9.42	%	4/22/2016	12/27/2017		8,296		8,458		8,379
Mitralign, Inc	Health Care Equipment & Supplies	—	—		9.48	%	4/22/2016	12/1/2018		1,667		1,604		1,658
Nabsys 2.0 LLC	Life Sciences Tools & Services	—	—		8.90	%	4/22/2016	10/13/2018		5,064		4,959		5,115
PhyMed Management LLC	Health Care Providers & Services	L+875	1.00	%	9.75	%	12/18/2015	5/18/2021		32,321		31,222		31,190
PQ Bypass, Inc.	Health Care Equipment & Supplies	L+885	—		9.46	%	4/21/2016	4/21/2020		5,000		4,933		4,950
Rapid Micro Biosystems, Inc.	Life Sciences Tools & Services	L+880	—		9.42	%	6/30/2015	6/30/2019		16,000		16,331		15,760
Rug Doctor LLC(3)	Diversified Consumer Services	L+975	1.50	%	11.25	%	12/23/2013	12/31/2018		9,111		8,927		9,111
Salient Partners, L.P	Asset Management	L+850	1.00	%	9.50	%	6/10/2015	6/9/2021		14,993		14,757		14,619
Scynexis, Inc	Pharmaceuticals	L+849	—		9.12	%	9/30/2016	9/30/2020		15,000		14,806		14,850
SentreHeart, Inc	Health Care Equipment & Supplies	L+885	—		9.46	%	11/15/2016	11/15/2020		7,500		7,341		7,325
SOINT, LLC(3)	Aerospace & Defense	—	—		15.00	%	6/8/2012	11/30/2018		2,386		2,381		2,386
Southern Auto Finance Company(6)	Consumer Finance	—	—		11.15	%	10/19/2011	12/4/2018		25,000		24,815		24,500
Sunesis Pharmaceuticals, Inc.	Pharmaceuticals	L+854	—		9.17	%	3/31/2016	4/1/2020		7,500		7,398		7,463
TierPoint, LLC	IT Services	L+875-887.5	1.00	%	9.75- 9.88	%	12/2/2014	12/2/2022		34,000		33,656		33,439
TMK Hawk Parent, Corp. (TriMark)	Trading Companies and Distributors	L+750	1.00	%	8.50	%	9/26/2014	10/1/2022		20,000		19,843		20,000
TouchTunes Interactive Networks, Inc	Media	L+825	1.00	%	9.25	%	5/28/2015	5/27/2022		14,000		13,826		13,825
Trevi Therapeutics, Inc	Pharmaceuticals	L+775	—		8.37	%	12/29/2014	6/29/2018		6,531		6,720		6,597
U.S. Anesthesia Partners Inc.	Health Care Providers & Services	L+925	1.00	%	10.25	%	9/24/2014	9/24/2020		30,000		29,795		29,700
Vapotherm, Inc	Health Care Equipment & Supplies	L+899	—		9.60	%	11/16/2016	5/16/2021		10,000		9,915		9,900
Varilease Finance, Inc	Multi-Sector Holdings	L+825	1.00	%	9.25	%	8/22/2014	8/24/2020		48,000		47,405		47,880
Total Bank Debt/Senior Secured Loans											$	804,917	$	788,254
Subordinated Debt/Corporate Notes — 3.1%
Alegeus Technologies Holdings Corp	Health Care Technology	L+1200	1.00	%	13.00	%	6/24/2012	2/15/2019		28,200	$	27,937	$	28,059

See notes to consolidated financial statements.

10

SOLAR CAPITAL LTD.

CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)

December 31, 2016

(in thousands, except share/unit amounts)

Description	Industry	Spread Above Index(10)	LIBOR Floor	Interest Rate(1)		Acquisition Date	Maturity Date		Shares/ Units		Cost		Fair Value
Preferred Equity — 1.6%
SOAGG LLC(3)(6)(7)	Aerospace & Defense	—	—	8.00	%	12/14/2010	6/30/2018		5,622	$	5,622	$	5,806
SOINT, LLC(3)(6)(7)	Aerospace & Defense	—	—	15.00	%	6/8/2012	6/30/2018		86,667		8,667		9,100
Total Preferred Equity										$	14,289	$	14,906
Common Equity/Equity Interests/Warrants—51.6%
Ark Real Estate Partners LP(2)(3)*	Diversified Real Estate Activities					3/12/2007			—	$	527	$	336
Ark Real Estate Partners II LP(2)(3)*	Diversified Real Estate Activities					10/23/2012			—		12		8
aTyr Pharma, Inc. Warrants*	Pharmaceuticals					11/18/2016			47,771		70		23
B Riley Financial Inc.(6)	Research & Consulting Services					3/16/2007			38,015		2,684		701
CardioDx, Inc. Warrants*	Health Care Providers & Services					6/18/2015			39,863		129		—
CAS Medical Systems, Inc. Warrants*	Health Care Equipment & Supplies					6/30/2016			48,491		38		29
Cianna Medical, Inc. Warrants*	Health Care Equipment & Supplies					9/28/2016			89,726		37		52
Conventus Orthopaedics, Inc. Warrants*	Health Care Equipment & Supplies					6/15/2016			157,500		65		67
Crystal Financial LLC(3)(6)	Diversified Financial Services					12/28/2012			280,303		280,737		305,000
Direct Buy Inc.(4)*	Multiline Retail					11/5/2012			76,999		—		—
PQ Bypass, Inc. Warrants*	Health Care Equipment & Supplies					4/21/2016			176,471		70		63
RD Holdco Inc. (Rug Doctor)(3)*	Diversified Consumer Services					12/23/2013			231,177		15,683		13,574
RD Holdco Inc. (Rug Doctor) Class B(3)*	Diversified Consumer Services					12/23/2013			522		5,216		5,216
RD Holdco Inc. (Rug Doctor) Warrants(3)*	Diversified Consumer Services					12/23/2013			30,370		381		168
Scynexis, Inc. Warrants*	Pharmaceuticals					9/30/2016			122,435		105		90
Senior Secured Unitranche Loan Program LLC(3)(6)	Asset Management					11/25/2015			—		101,878		100,653
Senior Secured Unitranche Loan Program II LLC(3)(6)	Asset Management					8/5/2016			—		46,963		47,363
SentreHeart, Inc. Warrants*	Health Care Equipment & Supplies					11/15/2016			196,369		101		98
Sunesis Pharmaceuticals, Inc. Warrants*	Pharmaceuticals					3/31/2016			104,001		118		118
Total Common Equity/Equity Interests/Warrants										$	454,814	$	473,559
Total Investments(9) — 142.1%										$	1,301,957	$	1,304,778
								Par Amount
Cash Equivalents — 33.7%
U.S. Treasury Bill	Government					12/29/2016	2/2/2017	$	310,000	$	309,894	$	309,894
Total Investments & Cash Equivalents —175.8%										$	1,611,851	$	1,614,672
Liabilities in Excess of Other Assets — (75.8%)													(696,165	)
Net Assets — 100.0%												$	918,507

(1) Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2016.

(2) Ark Real Estate Partners is held through SLRC ADI Corp., a taxable subsidiary.

(3) Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940 (“1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2016 in these controlled investments are as follows:

Name of Issuer	Fair Value at December 31, 2015		Gross Additions		Gross Reductions		Realized Gain (Loss)			Interest/ Dividend /Other Income		Fair Value at December 31, 2016
ARK Real Estate Partners LP	$	364	$	—	$	—	$	(29	)	$	—	$	336
ARK Real Estate Partners II LP		9		—		—		(1	)		—		8
AviatorCap SII, LLC I		914		—		417		—			85		497
AviatorCap SII, LLC II		350		—		350		—			15		—
Crystal Financial LLC		290,000		5,737		—		—			31,600		305,000
RD Holdco Inc. (Rug Doctor, common equity)		14,335		—		—		—			—		13,574
RD Holdco Inc. (Rug Doctor, class B)		5,216		—		—		—			—		5,216
RD Holdco Inc. (Rug Doctor, warrants)		214		—		—		—			—		168
Rug Doctor LLC		8,838		—		—		—			1,151		9,111
Senior Secured Unitranche Loan Program LLC		80,677		50,093		28,875		—			6,084		100,653
Senior Secured Unitranche Loan Program II LLC		—		63,093		16,130		—			1,228		47,363
SOAGG LLC		8,632		—		2,590		—			545		5,806
SOINT, LLC		5,705		—		3,318		—			602		2,386
SOINT, LLC (preferred equity)		9,316		—		—		—			1,304		9,100
	$	424,570	$	118,923	$	51,680	$	(30	)	$	42,614	$	499,218

See notes to consolidated financial statements.

11

SOLAR CAPITAL LTD.

CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)

December 31, 2016

(in thousands)

(4) Denotes investments in which we are an “Affiliated Person” but not exercising a controlling influence, as defined in the 1940 Act, due to beneficially owning, either directly or through one or more controlled companies, more than 5% but less than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2016 in these affiliated investments are as follows:

Name of Issuer	Fair Value at December 31, 2015		Gross Additions		Gross Reductions		Realized Gain (Loss)			Interest/ Dividend Income		Fair Value at December 31, 2016
Direct Buy Inc. (common equity)	$	—	$	—	$	—	$	—		$	—	$	—
Direct Buy Inc. (senior secured loan)		1,233		1,238		—		—			—		777
DSW Group Holdings LLC		—		—		—		197	†		—		—
	$	1,233	$	1,238	$	—	$	197		$	—	$	777

(5) The following entity is domiciled outside the United States and the investments are denominated in Canadian Dollars: Easyfinancial Services, Inc. in Canada.

(6) Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the Investment Company Act of 1940 (“1940 Act”), as amended. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2016, on a fair value basis, non-qualifying assets in the portfolio represented 31.6% of the total assets of the Company.

(7) Solar Capital Ltd.’s investments in SOAGG, LLC and SOINT, LLC include a two and one dollar investment in common shares, respectively.

(8) Bishop Lifting Products, Inc., SEI Holding I Corporation, Singer Equities, Inc. & Hampton Rubber Company are co-borrowers.

(9) Aggregate net unrealized depreciation for U.S. federal income tax purposes is $7,928; aggregate gross unrealized appreciation and depreciation for federal tax purposes is $27,715 and $35,643, respectively, based on a tax cost of $1,312,706. All of the Company’s investments are pledged as collateral against the borrowings outstanding on the revolving credit facilities.

(10) Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or PRIME rate. These instruments are typically subject to a LIBOR or PRIME rate floor.

* Non-income producing security.

** Investment is on non-accrual status.

† Represents estimated change in receivable balance.

Industry Classification	Percentage of Total Investments (at fair value) as of December 31, 2016
Diversified Financial Services		23.4	%
Asset Management		12.5	%
Health Care Providers & Services		10.4	%
Wireless Telecommunication Services		6.3	%
Pharmaceuticals		6.1	%
Health Care Equipment & Supplies		6.1	%
Professional Services		4.6	%
IT Services		4.6	%
Multi-Sector Holdings		3.7	%
Health Care Technology		3.3	%
Trading Companies & Distributors		3.1	%
Consumer Finance		2.4	%
Communications Equipment		2.4	%
Diversified Consumer Services		2.1	%
Life Sciences Tools & Services		1.6	%
Insurance		1.4	%
Aerospace & Defense		1.4	%
Chemicals		1.3	%
Media		1.1	%
Air Freight & Logistics		0.9	%
Thrifts & Mortgage Finance		0.7	%
Software		0.4	%
Multiline Retail		0.1	%
Research & Consulting Services		0.1	%
Diversified Real Estate Activities		0.0	%
Total Investments		100.0	%

See notes to consolidated financial statements.

12

SOLAR CAPITAL LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

March 31, 2017

(in thousands, except share amounts)

Note 1. Organization

Solar Capital LLC, a Maryland limited liability company, was formed in February 2007 and commenced operations on March 13, 2007 with initial capital of $1,200,000 of which 47.04% was funded by affiliated parties.

Immediately prior to our initial public offering, through a series of transactions, Solar Capital Ltd. merged with Solar Capital LLC, leaving Solar Capital Ltd. as the surviving entity (the “Merger”). Solar Capital Ltd. issued an aggregate of approximately 26.65 million shares of common stock and $125,000 in senior unsecured notes to the existing Solar Capital LLC unit holders in connection with the Merger. Solar Capital Ltd. had no assets or operations prior to completion of the Merger and as a result, the historical books and records of Solar Capital LLC have become the books and records of the surviving entity. The number of shares used to calculate weighted average shares for use in computations on a per share basis have been decreased retroactively by a factor of approximately 0.4022 for all periods prior to February 9, 2010. This factor represents the effective impact of the reduction in shares resulting from the Merger.

Solar Capital Ltd. (“Solar Capital”, the “Company”, “we”, “us” or “our”), a Maryland corporation formed in November 2007, is a closed-end, externally managed, non-diversified management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). Furthermore, as the Company is an investment company, it continues to apply the guidance in FASB Accounting Standards Codification (“ASC”) Topic 946. In addition, for tax purposes, the Company has elected to be treated as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).

On February 9, 2010, Solar Capital priced its initial public offering, selling 5.68 million shares, including the underwriters’ over-allotment, at a price of $18.50 per share. Concurrent with this offering, the Company’s senior management purchased an additional 600,000 shares through a private placement, also at $18.50 per share.

The Company’s investment objective is to maximize both current income and capital appreciation through debt and equity investments. The Company invests primarily in leveraged middle market companies in the form of senior secured loans, unitranche loans, mezzanine loans and equity securities. From time to time, we may also invest in public companies that are thinly traded.

Note 2. Significant Accounting Policies

The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“GAAP”), and include the accounts of the Company and its wholly-owned subsidiaries. The consolidated financial statements reflect all adjustments and reclassifications which, in the opinion of management, are necessary for the fair presentation of the results of the operations and financial condition for the periods presented. All significant intercompany balances and transactions have been eliminated. Certain prior period amounts may have been reclassified to conform to the current period presentation.

Interim consolidated financial statements are prepared in accordance with GAAP for interim financial information and pursuant to the requirements for reporting on Form 10-Q and Regulation S-X, as appropriate. Accordingly, they may not include all of the information and notes required by GAAP for annual consolidated financial statements. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements and the reported amounts of income and

13

SOLAR CAPITAL LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2017

(in thousands, except share amounts)

expenses during the reported periods. Changes in the economic environment, financial markets and any other parameters used in determining these estimates could cause actual results to differ materially. The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the fiscal year ending on December 31, 2017.

In the opinion of management, all adjustments, which are of a normal recurring nature, considered necessary for the fair presentation of financial statements, have been included.

The significant accounting policies consistently followed by the Company are:

(a) Investment transactions are accounted for on the trade date;

(b) Under procedures established by our board of directors (the “Board”), we value investments, including certain senior secured debt, subordinated debt and other debt securities with maturities greater than 60 days, for which market quotations are readily available, at such market quotations (unless they are deemed not to represent fair value). We attempt to obtain market quotations from at least two brokers or dealers (if available, otherwise from a principal market maker or a primary market dealer or other independent pricing service). We utilize mid-market pricing as a practical expedient for fair value unless a different point within the range is more representative. If and when market quotations are deemed not to represent fair value, we typically utilize independent third-party valuation firms to assist us in determining fair value. Accordingly, such investments go through our multi-step valuation process as described below. In each case, independent valuation firms consider observable market inputs together with significant unobservable inputs in arriving at their valuation recommendations. Debt investments with maturities of 60 days or less shall each be valued at cost plus accreted discount, or minus amortized premium, which is expected to approximate fair value, unless such valuation, in the judgment of Solar Capital Partners, LLC (the “Investment Adviser”), does not represent fair value, in which case such investments shall be valued at fair value as determined in good faith by or under the direction of our Board. Investments that are not publicly traded or whose market quotations are not readily available are valued at fair value as determined in good faith by or under the direction of our Board. Such determination of fair values involves subjective judgments and estimates.

With respect to investments for which market quotations are not readily available or when such market quotations are deemed not to represent fair value, our Board has approved a multi-step valuation process each quarter, as described below:

(1) our quarterly valuation process begins with each portfolio company or investment being initially valued by the investment professionals of the Investment Adviser responsible for the portfolio investment;

(2) preliminary valuation conclusions are then documented and discussed with senior management of the Investment Adviser;

(3) independent valuation firms engaged by our Board conduct independent appraisals and review the Investment Adviser’s preliminary valuations and make their own independent assessment for all material assets;

(4) the audit committee of the Board reviews the preliminary valuation of the Investment Adviser and that of the independent valuation firm and responds to the valuation recommendation of the independent valuation firm to reflect any comments; and

14

SOLAR CAPITAL LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2017

(in thousands, except share amounts)

(5) the Board discusses valuations and determines the fair value of each investment in our portfolio in good faith based on the input of the Investment Adviser, the respective independent valuation firm and the audit committee.

Investments in all asset classes are valued utilizing a market approach, an income approach, or both approaches, as appropriate. However, in accordance with ASC 820-10, certain investments that qualify as investment companies in accordance with ASC 946, may be valued using net asset value as a practical expedient for fair value. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities (including a business). The income approach uses valuation approaches to convert future amounts (for example, cash flows or earnings) to a single present amount (discounted). The measurement is based on the value indicated by current market expectations about those future amounts. In following these approaches, the types of factors that we may take into account in fair value pricing our investments include, as relevant: available current market data, including relevant and applicable market trading and transaction comparables, applicable market yields and multiples, security covenants, call protection provisions, the nature and realizable value of any collateral, the portfolio company’s ability to make payments, its earnings and discounted cash flows, the markets in which the portfolio company does business, comparisons of financial ratios of peer companies that are public, M&A comparables, our principal market (as the reporting entity) and enterprise values, among other factors. When available, broker quotations and/or quotations provided by pricing services are considered as an input in the valuation process. For the three months ended March 31, 2017, there has been no change to the Company’s valuation approaches or techniques and the nature of the related inputs considered in the valuation process.

ASC Topic 820 classifies the inputs used to measure these fair values into the following hierarchy:

Level 1: Quoted prices in active markets for identical assets or liabilities, accessible by the Company at the measurement date.

Level 2: Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or other observable inputs other than quoted prices.

Level 3: Unobservable inputs for the asset or liability.

In all cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each investment. The exercise of judgment is based in part on our knowledge of the asset class and our prior experience.

(c) Gains or losses on investments are calculated by using the specific identification method.

(d) The Company records dividend income and interest, adjusted for amortization of premium and accretion of discount, on an accrual basis. Loan origination fees, original issue discount, and market discounts are capitalized and we amortize such amounts into income using the effective interest method or on a straight-line basis, as applicable. Upon the prepayment of a loan, any unamortized loan origination fees are recorded as interest income. We record call premiums received on loans repaid as interest income when we receive such amounts. Capital structuring fees, amendment fees, consent fees, and any other non-recurring fee income as well as management fee and other fee income for services rendered, if any, are recorded as other income when earned.

15

SOLAR CAPITAL LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2017

(in thousands, except share amounts)

(e) The Company intends to comply with the applicable provisions of the Internal Revenue Code pertaining to regulated investment companies to make distributions of taxable income sufficient to relieve it of substantially all U.S. federal income taxes. The Company, at its discretion, may carry forward taxable income in excess of calendar year distributions and pay a 4% excise tax on this income. The Company will accrue excise tax on such estimated excess taxable income as appropriate.

(f) Book and tax basis differences relating to stockholder distributions and other permanent book and tax differences are typically reclassified among the Company’s capital accounts annually. In addition, the character of income and gains to be distributed is determined in accordance with income tax regulations that may differ from GAAP.

(g) Distributions to common stockholders are recorded as of the record date. The amount to be paid out as a distribution is determined by the Board. Net realized capital gains, if any, are generally distributed or deemed distributed at least annually.

(h) In accordance with Regulation S-X and ASC Topic 810—Consolidation, the Company consolidates its interest in investment company subsidiaries, financing subsidiaries and certain wholly-owned holding companies that serve to facilitate investment in portfolio companies. In addition, the Company may also consolidate any controlled operating companies substantially all of whose business consists of providing services to the Company.

(i) The accounting records of the Company are maintained in U.S. dollars. Any assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the rate of exchange of such currencies against U.S. dollars on the date of valuation. The Company will not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. Such fluctuations would be included with the net unrealized gain or loss from investments. The Company’s investments in foreign securities, if any, may involve certain risks, including without limitation: foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments in terms of U.S. dollars and therefore the earnings of the Company.

(j) The Company has made an irrevocable election to apply the fair value option of accounting to its senior secured credit facility (the “Credit Facility”), its unsecured senior notes due 2022 (the “2022 Unsecured Notes”) and its senior secured notes (the “Senior Secured Notes”) (see note 6 and 8), in accordance with ASC 825-10. The Company uses an independent third-party valuation firm to assist in measuring their fair value.

(k) In accordance with ASC 835-30, the Company records origination and other expenses related to certain debt issuances as a direct deduction from the carrying amount of the debt liability. These expenses are deferred and amortized using either the effective interest method or the straight-line method over the stated life. The straight-line method may be used on revolving facilities and when it approximates the effective yield method.

(l) The Company may enter into forward exchange contracts in order to hedge against foreign currency risk. These contracts are marked-to-market by recognizing the difference between the contract exchange rate and the current market rate as unrealized appreciation or depreciation. Realized gains or losses are recognized when contracts are settled.

16

SOLAR CAPITAL LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2017

(in thousands, except share amounts)

(m) The Company records expenses related to shelf registration statements and applicable equity offering costs as prepaid assets. These expenses are typically charged as a reduction of capital upon utilization, in accordance with ASC 946-20-25. Certain subsequent costs are expensed per the AICPA Audit & Accounting Guide for Investment Companies.

(n) Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when principal or interest cash payments are past due 30 days or more and/or when it is no longer probable that principal or interest cash payments will be collected. Such non-accrual investments are restored to accrual status if past due principal and interest are paid in cash, and in management’s judgment, are likely to continue timely payment of their remaining principal and interest obligations. Cash interest payments received on investments may be recognized as income or applied to principal depending on management’s judgment.

(o) The Company defines cash equivalents as securities that are readily convertible into known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only securities with a maturity of three months or less would qualify, with limited exceptions. The Company believes that certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities would qualify as cash equivalents.

Recent Accounting Pronouncements

In October 2016, the U.S. Securities and Exchange Commission adopted new rules and amended rules (together, “final rules”) interned to modernize the reporting and disclosure of information by registered investment companies. In part, the final rules amend Regulation S-X and require standardized, enhanced disclosure about derivatives in investment company financial statements, as well as other amendments. The compliance date for the amendments to Regulation S-X is August 1, 2017. The Company is currently evaluating the impact that the adoption of the amendments to Regulation S-X will have on its consolidated financial statements and disclosures.

In November 2016, FASB issued ASU 2016-18, Statement of Cash Flows, which will amend FASB ASC 230. The amendments in this Update require that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. The amendments in this Update apply to all entities that have restricted cash or restricted cash equivalents and are required to present a statement of cash flows under Topic 230. For public business entities, the amendments are effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted, including adoption in an interim period. The Company is evaluating the impact of ASU 2016-18 on its consolidated financial statements and disclosures.

In December 2016, the FASB issued ASU 2016-19, Technical Corrections and Improvements. As part of this guidance, ASU 2016-19 amends FASB ASC 820 to clarify the difference between a valuation approach and a valuation technique. The amendment also requires an entity to disclose when there has been a change in either or both a valuation approach and/or a valuation technique. ASU 2016-19 is effective on a prospective basis for financial statements issued for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016 on a prospective basis. The Company has evaluated the impact of ASU 2016-19 on its consolidated financial statements and disclosures and determined that the adoption of ASU 2016-19 has not had a material impact on its consolidated financial statements.

17

SOLAR CAPITAL LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2017

(in thousands, except share amounts)

Note 3. Agreements

Solar Capital has an Advisory Agreement with the Investment Adviser, under which the Investment Adviser will manage the day-to-day operations of, and provide investment advisory services to, Solar Capital. For providing these services, the Investment Adviser receives a fee from Solar Capital, consisting of two components—a base management fee and an incentive fee. The base management fee is determined by taking the average value of Solar Capital’s gross assets at the end of the two most recently completed calendar quarters calculated at an annual rate of 2.00%. For purposes of computing the base management fee, gross assets exclude temporary assets acquired at the end of each fiscal quarter for purposes of preserving investment flexibility in the next fiscal quarter. Temporary assets include, but are not limited to, U.S. treasury bills, other short-term U.S. government or government agency securities, repurchase agreements or cash borrowings.

The incentive fee has two parts, as follows: one part is calculated and payable quarterly in arrears based on Solar Capital’s pre-incentive fee net investment income for the immediately preceding calendar quarter. For this purpose, pre-incentive fee net investment income means interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that we receive from portfolio companies) accrued during the calendar quarter, minus Solar Capital’s operating expenses for the quarter (including the base management fee, any expenses payable under the Administration Agreement, and any interest expense and distributions paid on any issued and outstanding preferred stock, but excluding the incentive fee). Pre-incentive fee net investment income does not include any realized capital gains or losses, or unrealized capital appreciation or depreciation. Pre-incentive fee net investment income, expressed as a rate of return on the value of Solar Capital’s net assets at the end of the immediately preceding calendar quarter, is compared to the hurdle rate of 1.75% per quarter (7% annualized). Solar Capital pays the Investment Adviser an incentive fee with respect to Solar Capital’s pre-incentive fee net investment income in each calendar quarter as follows: (1) no incentive fee in any calendar quarter in which Solar Capital’s pre-incentive fee net investment income does not exceed the hurdle rate; (2) 100% of Solar Capital’s pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than 2.1875% in any calendar quarter; and (3) 20% of the amount of Solar Capital’s pre-incentive fee net investment income, if any, that exceeds 2.1875% in any calendar quarter. These calculations are appropriately pro-rated for any period of less than three months.

The second part of the incentive fee is determined and payable in arrears as of the end of each calendar year (or upon termination of the Advisory Agreement, as of the termination date), and will equal 20% of Solar Capital’s cumulative realized capital gains less cumulative realized capital losses, unrealized capital depreciation (unrealized depreciation on a gross investment-by-investment basis at the end of each calendar year) and all net capital gains upon which prior performance-based capital gains incentive fee payments were previously made to the Investment Adviser. For financial statement purposes, the second part of the incentive fee is accrued based upon 20% of cumulative net realized gains and net unrealized capital appreciation. No accrual was required for the three months ended March 31, 2017 and 2016.

For the three months ended March 31, 2017 and 2016, the Company recognized $6,719 and $6,748, respectively, in base management fees and $4,083 and $4,030, respectively, in performance-based incentive fees. For the three months ended March 31, 2017 and 2016, $0 and $795, respectively, of such performance-based incentive fees were waived. The voluntary fee waiver for the three months ended March 31, 2016 was made at the Investment Adviser’s discretion and was subject to recapture by the Investment Adviser and reimbursement by the Company when net investment income during fiscal 2016 equaled or exceeded distributions declared in fiscal 2016.

18

SOLAR CAPITAL LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2017

(in thousands, except share amounts)

Solar Capital has also entered into an Administration Agreement with Solar Capital Management, LLC (the “Administrator”) under which the Administrator provides administrative services to Solar Capital. For providing these services, facilities and personnel, Solar Capital reimburses the Administrator for Solar Capital’s allocable portion of overhead and other expenses incurred by the Administrator in performing its obligations under the Administration Agreement, including rent. The Administrator will also provide, on Solar Capital’s behalf, managerial assistance to those portfolio companies to which Solar Capital is required to provide such assistance. The Company typically reimburses the Administrator on a quarterly basis.

For the three months ended March 31, 2017 and 2016, the Company recognized expenses under the Administration Agreement of $1,335 and $1,319, respectively. No managerial assistance fees were accrued or collected for the three months ended March 31, 2017 and 2016.

Note 4. Net Asset Value Per Share

At March 31, 2017, the Company’s total net assets and net asset value per share were $918,766 and $21.75, respectively. This compares to total net assets and net asset value per share at December 31, 2016 of $918,507 and $21.74, respectively.

Note 5. Earnings Per Share

The following table sets forth the computation of basic and diluted net increase in net assets per share resulting from operations, pursuant to ASC 260-10, for the three months ended March 31, 2017 and 2016:

	Three months ended March 31,
	2017		2016
Earnings per share (basic & diluted)
Numerator—net increase in net assets resulting from operations:	$	17,158	$	28,177
Denominator—weighted average shares:		42,248,525		42,287,207
Earnings per share:	$	0.41	$	0.67

Note 6. Fair Value

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a framework for measuring fair value that includes a hierarchy used to classify the inputs used in measuring fair value. The hierarchy prioritizes the inputs to valuations used to measure fair value into three levels. The level in the fair value hierarchy within which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The levels of the fair value hierarchy are as follows:

Level 1. Financial assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the Company has the ability to access.

Level 2. Financial assets and liabilities whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the asset or liability. Level 2 inputs include the following:

a) Quoted prices for similar assets or liabilities in active markets;

19

SOLAR CAPITAL LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2017

(in thousands, except share amounts)

b) Quoted prices for identical or similar assets or liabilities in non-active markets;

c) Pricing models whose inputs are observable for substantially the full term of the asset or liability; and

d) Pricing models whose inputs are derived principally from or corroborated by observable market data through correlation or other means for substantially the full term of the asset or liability.

Level 3.Financial assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s and, if applicable, an independent third-party valuation firm’s own assumptions about the assumptions a market participant would use in pricing the asset or liability.

When the inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement in its entirety. For example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2) and unobservable (Level 3).

Gains and losses for assets and liabilities categorized within the Level 3 table below may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3).

A review of fair value hierarchy classifications is conducted on a quarterly basis. Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities. Such reclassifications are reported as transfers in/out of the appropriate category as of the end of the quarter in which the reclassifications occur.

The following tables present the balances of assets and liabilities measured at fair value on a recurring basis, as of March 31, 2017 and December 31, 2016:

Fair Value Measurements

As of March 31, 2017

	Level 1		Level 2		Level 3		Measured at Net Asset Value*		Total
Assets:
Bank Debt/Senior Secured Loans	$	—	$	25,760	$	780,479	$	—	$	806,239
Subordinated Debt/Corporate Notes		—		—		28,200		—		28,200
Preferred Equity		—		—		14,671		—		14,671
Common Equity/Equity Interests/Warrants		570		—		324,490		149,325		474,385
Total Investments	$	570	$	25,760	$	1,147,840	$	149,325	$	1,323,495
Liabilities:
Credit Facility, Senior Secured Notes and 2022 Unsecured Notes	$	—	$	—	$	275,000	$	—	$	275,000

* In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the

20

SOLAR CAPITAL LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2017

(in thousands, except share amounts)

amounts presented in the Consolidated Statements of Assets and Liabilities. The two portfolio investments in this category are Senior Secured Unitranche Loan Program, LLC (“SSLP”) and Senior Secured Unitranche Loan Program II, LLC (“SSLP II”). See Note 13 & 14, respectively, for more information on these investments, including their investment strategies and the Company’s unfunded equity commitments to SSLP and SSLP II. Neither of these investments is redeemable by the Company absent an election by the members of the entities to liquidate all investments and distribute the proceeds to the members.

Fair Value Measurements

As of December 31, 2016

	Level 1		Level 2		Level 3		Measured at Net Asset Value*		Total
Assets:
Bank Debt/Senior Secured Loans	$	—	$	28,744	$	759,510	$	—	$	788,254
Subordinated Debt/Corporate Notes		—		—		28,059		—		28,059
Preferred Equity		—		—		14,906		—		14,906
Common Equity/Equity Interests/Warrants		701		—		324,842		148,016		473,559
Total Investments	$	701	$	28,744	$	1,127,317	$	148,016	$	1,304,778
Liabilities:
Credit Facility, Senior Secured Notes and 2022 Unsecured Notes	$	—	$	—	$	290,200	$	—	$	290,200

* In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities.

21

SOLAR CAPITAL LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2017

(in thousands, except share amounts)

The following tables provide a summary of the changes in fair value of Level 3 assets and liabilities for the three months ended March 31, 2017 and the year ended December 31, 2016 as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets and liabilities still held at March 31, 2017 and December 31, 2016:

Fair Value Measurements Using Level 3 Inputs

	Bank Debt/ Senior Secured Loans			Subordinated Debt/ Corporate Notes		Preferred Equity			Common Equity/ Equity Interests/ Warrants
Fair value, December 31, 2016	$	759,510		$	28,059	$	14,906		$	324,842
Total gains or losses included in earnings:
Net realized gain (loss)		328			—		—			—
Net change in unrealized gain (loss)		81			114		92			(482	)
Purchase of investment securities		100,344			27		—			130
Proceeds from dispositions of investment securities		(79,784	)		—		(327	)		—
Transfers in/out of Level 3		—			—		—			—
Fair value, March 31, 2017	$	780,479		$	28,200	$	14,671		$	324,490
Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
Net change in unrealized gain (loss)	$	505		$	114	$	92		$	(482	)

During the three months ended March 31, 2017, there were no transfers in and out of Levels 1 and 2.

The following table shows a reconciliation of the beginning and ending balances for fair valued liabilities measured using significant unobservable inputs (Level 3) for the three months ended March 31, 2017:

Credit Facility, Senior Secured Notes and 2022 Unsecured Notes	For the three months ended March 31, 2017
Beginning fair value	$	290,200
Net realized (gain) loss		—
Net change in unrealized (gain) loss		—
Borrowings		197,500
Repayments		(212,700	)
Transfers in/out of Level 3		—
Ending fair value	$	275,000

The Company has made an irrevocable election to apply the fair value option of accounting to the Credit Facility, the Senior Secured Notes and the 2022 Unsecured Notes, in accordance with ASC 825-10. On March 31, 2017, there were borrowings of $50,000, $75,000 and $150,000, respectively, on the Credit Facility, the Senior Secured Notes and the 2022 Unsecured Notes. The Company used an independent third-party

22

SOLAR CAPITAL LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2017

(in thousands, except share amounts)

valuation firm to assist in measuring the fair value of the Credit Facility, the Senior Secured Notes and the 2022 Unsecured Notes.

Fair Value Measurements Using Level 3 Inputs

	Bank Debt/ Senior Secured Loans			Subordinated Debt/ Corporate Notes			Preferred Equity			Common Equity/ Equity Interests/ Warrants
Fair value, December 31, 2015	$	800,291		$	67,314		$	17,948		$	310,239
Total gains or losses included in earnings:
Net realized gain (loss)		702			77			—			(144	)
Net change in unrealized gain (loss)		10,613			8,479			(452	)		8,360
Purchase of investment securities		317,268			189			—			6,387
Proceeds from dispositions of investment securities		(369,364	)		(48,000	)		(2,590	)		—
Transfers in/out of Level 3		—			—			—			—
Fair value, December 31, 2016	$	759,510		$	28,059		$	14,906		$	324,842
Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
Net change in unrealized gain (loss)	$	6,943		$	602		$	(452	)	$	8,362

During the year ended December 31, 2016, there were no transfers in and out of Levels 1 and 2.

The following table shows a reconciliation of the beginning and ending balances for fair valued liabilities measured using significant unobservable inputs (Level 3) for the year ended December 31, 2016:

Credit Facility, Senior Secured Notes and 2022 Unsecured Notes	For the year ended December 31, 2016
Beginning fair value	$	332,900
Net realized (gain) loss		—
Net change in unrealized (gain) loss		—
Borrowings		728,500
Repayments		(771,200	)
Transfers in/out of Level 3		—
Ending fair value	$	290,200

The Company has made an irrevocable election to apply the fair value option of accounting to the Credit Facility, the Senior Secured Notes and the 2022 Unsecured Notes, in accordance with ASC 825-10. On December 31, 2016, there were borrowings of $165,200, $75,000 and $50,000, respectively, on the Credit Facility, the Senior Secured Notes and the 2022 Unsecured Notes. The Company used an independent third-party valuation firm to assist in measuring the fair value of the Credit Facility, the Senior Secured Notes and the 2022 Unsecured Notes.

23

SOLAR CAPITAL LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2017

(in thousands, except share amounts)

Quantitative Information about Level 3 Fair Value Measurements

The Company typically determines the fair value of its performing debt investments utilizing a yield analysis. In a yield analysis, a price is ascribed for each investment based upon an assessment of current and expected market yields for similar investments and risk profiles. Additional consideration is given to current contractual interest rates, relative maturities and other key terms and risks associated with an investment. Among other factors, a significant determinant of risk is the amount of leverage used by the portfolio company relative to the total enterprise value of the company, and the rights and remedies of our investment within each portfolio company.

Significant unobservable quantitative inputs typically used in the fair value measurement of the Company’s Level 3 assets and liabilities primarily reflect current market yields, including indices, and readily available quotes from brokers, dealers, and pricing services as indicated by comparable assets and liabilities, as well as enterprise values, returns on equity and earnings before income taxes, depreciation and amortization (“EBITDA”) multiples of similar companies, and comparable market transactions for equity securities.

Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of March 31, 2017 is summarized in the table below:

	Asset or Liability	Fair Value at March 31, 2017		Principal Valuation Technique/Methodology	Unobservable Input	Range (Weighted Average)
Bank Debt/Senior Secured Loans	Asset	$	780,479	Yield Analysis	Market Yield	6.8% – 20.7% (11.5%)
Subordinated Debt/Corporate Note	Asset	$	28,200	Yield Analysis	Market Yield	15.0% – 15.0% (15.0%)
Preferred Equity	Asset	$	14,671	Yield Analysis	Market Yield	8.0% – 11.3% (10.0%)
Common Equity/Equity Interests/Warrants	Asset	$ $	18,790 305,700	Enterprise Value Enterprise Value	EBITDA Multiple Return on Equity	5.5x – 6.5x (6.3x) 7.7% – 13.6% (13.6%)
Credit Facility	Liability	$	50,000	Yield Analysis	Market Yield	L+1.4% – L+4.8% (L+2.0%)
Senior Secured Notes	Liability	$	75,000	Yield Analysis	Market Yield	5.6% – 6.1% (5.9%)
2022 Unsecured Notes	Liability	$	150,000	Yield Analysis	Market Yield	4.5% – 4.7% (4.5%)

Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of December 31, 2016 is summarized in the table below:

	Asset or Liability	Fair Value at December 31, 2016		Principal Valuation Technique/Methodology	Unobservable Input	Range (Weighted Average)
Bank Debt/Senior Secured Loans	Asset	$ $	758,733 777	Yield Analysis Enterprise Value	Market Yield EBITDA Multiple	8.2% – 51.6% (11.5%) 4.0x – 5.0x (4.5x)
Subordinated Debt/Corporate Note	Asset	$	28,059	Yield Analysis	Market Yield	14.9% – 14.9% (14.9%)
Preferred Equity	Asset	$	14,906	Yield Analysis	Market Yield	8.0% – 11.3% (10.0%)
Common Equity/Equity Interests/Warrants	Asset	$ $	19,842 305,000	Enterprise Value Enterprise Value	EBITDA Multiple Return on Equity	5.5x – 6.5x (6.3x) 7.7% – 12.5% (11.9%)
Credit Facility	Liability	$	165,200	Yield Analysis	Market Yield	L+1.4% – L+4.8% (L+2.0%)
Senior Secured Notes	Liability	$	75,000	Yield Analysis	Market Yield	5.6% – 6.1% (5.9%)
2022 Unsecured Notes	Liability	$	50,000	Yield Analysis	Market Yield	4.4% – 4.7% (4.4%)

Significant increases or decreases in any of the above unobservable inputs in isolation, including unobservable inputs used in deriving bid-ask spreads, if applicable, could result in significantly lower or higher fair value measurements for such assets and liabilities.

24

SOLAR CAPITAL LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2017

(in thousands, except share amounts)

Note 7. Derivatives

The Company is exposed to foreign exchange risk through its investments denominated in foreign currencies. The Company may mitigate this risk through the use of foreign currency forward contracts, borrowing in local currency under its Credit Facility, or similar. As an investment company, all changes in the fair value of assets, including changes caused by foreign currency fluctuation, flow through current earnings.

As of March 31, 2017 and December 31, 2016, there were no open forward foreign currency contracts outstanding. The Company also had no derivatives designated as hedging instruments at March 31, 2017 and December 31, 2016.

Note 8. Debt

Unsecured Senior Notes

On November 16, 2012, the Company and U.S. Bank National Association entered into an Indenture and a First Supplemental Indenture relating to the Company’s issuance, offer and sale of $100,000 aggregate principal amount of its 6.75% Unsecured Senior Notes due 2042 (the “2042 Unsecured Notes”). The 2042 Unsecured Notes will mature on November 15, 2042 and may be redeemed in whole or in part at the Company’s option at any time or from time to time on or after November 15, 2017 at a redemption price of $25 per security plus accrued and unpaid interest. The 2042 Unsecured Notes bear interest at a rate of 6.75% per year payable quarterly on February 15, May 15, August 15 and November 15 of each year. The 2042 Unsecured Notes are direct senior unsecured obligations of the Company.

On November 8, 2016, the Company closed a private offering of $50 million of the 2022 Unsecured Notes with a fixed interest rate of 4.40% and a maturity date of May 8, 2022. Interest on the 2022 Unsecured Notes is due semi-annually on May 8 and November 8. The 2022 Unsecured Notes were issued in a private placement only to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

On February 15, 2017, the Company closed a private offering of $100,000 of additional 2022 Unsecured Notes with a fixed interest rate of 4.60% and a maturity date of May 8, 2022. Interest on the 2022 Unsecured Notes is due semi-annually on May 8 and November 8. The 2022 Unsecured Notes were issued in a private placement only to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

Revolving and Term Loan Facility

On September 30, 2016, the Company entered into a second Credit Facility amendment. Post amendment, the Credit Facility was composed of $505,000 of revolving credit and $50,000 of term loans. Borrowings generally bear interest at a rate per annum equal to the base rate plus a range of 2.00-2.25% or the alternate base rate plus 1.00%-1.25%. The Credit Facility has no LIBOR floor requirement. The Credit Facility matures in September 2021 and includes ratable amortization in the final year. The Credit Facility may be increased up to $800,000 with additional new lenders or an increase in commitments from current lenders. The Credit Facility contains certain customary affirmative and negative covenants and events of default. In addition, the Credit Facility contains certain financial covenants that among other things, requires the Company to maintain a minimum shareholder’s equity and a minimum asset coverage ratio. The Company also pays issuers of funded term loans quarterly in arrears a commitment fee at the rate of 0.25% per annum on the average daily outstanding balance. On February 23, 2017, the Company prepaid its non-extending lenders and terminated their

25

SOLAR CAPITAL LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2017

(in thousands, except share amounts)

commitments, reducing total outstanding revolving credit commitments by $110,000 to $395,000. At March 31, 2017, outstanding USD equivalent borrowings under the Credit Facility totaled $50,000, comprised solely of outstanding term loans.

Senior Secured Notes

On May 10, 2012, the Company closed a private offering of $75,000 of Senior Secured Notes with a fixed interest rate of 5.875% and a maturity date of May 10, 2017. Interest on the Senior Secured Notes is due semi-annually on May 10 and November 10. The Senior Secured Notes were issued in a private placement only to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

Certain covenants on our issued debt may restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain our status as a RIC under Subchapter M of the Code.

The Company has made an irrevocable election to apply the fair value option of accounting to its Credit Facility, Senior Secured Notes and 2022 Unsecured Notes, in accordance with ASC 825-10. We believe accounting for the Credit Facility, Senior Secured Notes and 2022 Unsecured Notes at fair value better aligns the measurement methodologies of assets and liabilities, which may mitigate certain earnings volatility. ASC 825-10 requires entities to display the fair value of the selected assets and liabilities on the face of the Consolidated Statement of Assets and Liabilities and changes in fair value of the Credit Facility, the Senior Secured Notes and the 2022 Unsecured Notes are reported in the Consolidated Statement of Operations.

The average annualized interest cost for all borrowings for the three months ended March 31, 2017 and the year ended December 31, 2016 was 5.13% and 4.11%, respectively. These costs are exclusive of other credit facility expenses such as unused fees, agency fees and other prepaid expenses related to establishing and/or amending the Credit Facility, the 2022 Unsecured Notes, the 2042 Unsecured Notes, and the Senior Secured Notes (collectively the “Credit Facilities”), if any. During the three months ended March 31, 2017, the Company expensed $536 in conjunction with the February issue of 2022 Unsecured Notes. During the year ended December 31, 2016, the Company expensed $2,781 in conjunction with the September 2016 amendment to the Credit Facility and $280 in conjunction with the November issue of the 2022 Unsecured Notes. The maximum amounts borrowed on the Credit Facilities during the three months ended March 31, 2017 and the year ended December 31, 2016 were $399,200 and $610,900, respectively.

26

SOLAR CAPITAL LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2017

(in thousands, except share amounts)

Note 9. Financial Highlights and Senior Securities Table

The following is a schedule of financial highlights for the three months ended March 31, 2017 and for the year ended December 31, 2016:

	Three months ended March 31, 2017 (unaudited)			Year ended December 31, 2016
Per Share Data:(a)
Net asset value, beginning of year	$	21.74		$	20.79
Net investment income		0.39			1.68
Net realized and unrealized gain		0.02			0.84
Net increase in net assets resulting from operations		0.41			2.52
Distributions to stockholders:
From net investment income		(0.40	)		(1.60	)
Anti-dilution		—			0.03
Net asset value, end of period	$	21.75		$	21.74
Per share market value, end of period	$	22.61		$	20.82
Total Return(b)		10.52	%		37. 49	%
Net assets, end of period	$	918,766		$	918,507
Shares outstanding, end of period		42,248,525			42,248,525
Ratios to average net assets(c):
Net investment income		1.78	%		7.91	%
Operating expenses		1.35	%		6.25	%
Interest and other credit facility expenses*		0.62	%		2.73	%
Total expenses		1.97	%		8.98	%
Average debt outstanding	$	369,830		$	495,795
Portfolio turnover ratio		6.5	%		31.0	%

(a) Calculated using the average shares outstanding method.

(b) Total return is based on the change in market price per share during the period and takes into account distributions, if any, reinvested in accordance with the dividend reinvestment plan. Total return does not include a sales load.

(c) Not annualized for periods less than one year.

* Ratios shown without the non-recurring costs associated with the amendment of the Credit Facility and establishment of the 2022 Unsecured Notes would be 0.56% and 2.39%, respectively for the periods shown.

27

SOLAR CAPITAL LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2017

(in thousands, except share amounts)

Information about our senior securities is shown in the following table as of each year ended December 31 since the Company commenced operations, unless otherwise noted. The “—” indicates information which the SEC expressly does not require to be disclosed for certain types of senior securities.

Class and Year	Total Amount Outstanding(1)		Asset Coverage Per  Unit(2)		Involuntary Liquidating Preference Per Unit(3)		Average Market Value Per Unit(4)
Revolving Credit Facilities
Fiscal 2017 (through March 31, 2017)	$	—	$	—		—		N/A
Fiscal 2016		115,200		990		—		N/A
Fiscal 2015		207,900		1,459		—		N/A
Fiscal 2014		—		—		—		N/A
Fiscal 2013		—		—		—		N/A
Fiscal 2012		264,452		1,510		—		N/A
Fiscal 2011		201,355		3,757		—		N/A
Fiscal 2010		400,000		2,668		—		N/A
Fiscal 2009		88,114		8,920		—		N/A
2022 Unsecured Notes
Fiscal 2017 (through March 31, 2017)	$	150,000	$	1,380		—		N/A
Fiscal 2016		50,000		430		—		N/A
2042 Unsecured Notes
Fiscal 2017 (through March 31, 2017)	$	100,000	$	920		—	$	1,010
Fiscal 2016		100,000		859		—		1,002
Fiscal 2015		100,000		702		—		982
Fiscal 2014		100,000		2,294		—		943
Fiscal 2013		100,000		2,411		—		934
Fiscal 2012		100,000		571		—		923
Senior Secured Notes
Fiscal 2017 (through March 31, 2017)	$	75,000	$	690		—		N/A
Fiscal 2016		75,000		645		—		N/A
Fiscal 2015		75,000		527		—		N/A
Fiscal 2014		75,000		1,721		—		N/A
Fiscal 2013		75,000		1,808		—		N/A
Fiscal 2012		75,000		428		—		N/A
Term Loans
Fiscal 2017 (through March 31, 2017)	$	50,000	$	460		—		N/A
Fiscal 2016		50,000		430		—		N/A
Fiscal 2015		50,000		351		—		N/A
Fiscal 2014		50,000		1,147		—		N/A
Fiscal 2013		50,000		1,206		—		N/A
Fiscal 2012		50,000		285		—		N/A
Fiscal 2011		35,000		653		—		N/A
Fiscal 2010		35,000		233		—		N/A
Total Senior Securities
Fiscal 2017 (through March 31, 2017)	$	375,000	$	3,450		—		N/A
Fiscal 2016		390,200		3,354		—		N/A
Fiscal 2015		432,900		3,039		—		N/A
Fiscal 2014		225,000		5,162		—		N/A
Fiscal 2013		225,000		5,425		—		N/A
Fiscal 2012		489,452		2,794		—		N/A
Fiscal 2011		236,355		4,410		—		N/A
Fiscal 2010		435,000		2,901		—		N/A
Fiscal 2009		88,114		8,920		—		N/A

(1) Total amount of each class of senior securities outstanding at the end of the period presented.

28

SOLAR CAPITAL LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2017

(in thousands, except share amounts)

(2) The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of March 31, 2017, asset coverage was 345.0%.

(3) The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it.

(4) Not applicable except for the 2042 Unsecured Notes which are publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2017, 2016, 2015, 2014, 2013 and 2012 periods was $100,983, $100,175, $98,196, $94,301, $93,392, and $92,302, respectively.

Note 10. Crystal Financial LLC

On December 28, 2012, we completed the acquisition of Crystal Capital Financial Holdings LLC (“Crystal Financial”), a commercial finance company focused on providing asset-based and other secured financing solutions (the “Crystal Acquisition”). We invested $275,000 in cash to effect the Crystal Acquisition. Crystal Financial owned approximately 98% of the outstanding ownership interest in Crystal Financial LLC. The remaining financial interest was held by various employees of Crystal Financial LLC, through their investment in Crystal Management LP. Crystal Financial LLC had a diversified portfolio of 23 loans having a total par value of approximately $400,000 at November 30, 2012 and a $275,000 committed revolving credit facility. On January 27, 2014, the revolving credit facility was expanded to $300,000. On March 31, 2014, we exchanged $137,500 of our equity interest in Crystal Financial in exchange for $137,500 in floating rate senior secured notes in Crystal Financial bearing interest at LIBOR plus 9.50%, maturing on March 31, 2019. On May 18, 2015, the revolving credit facility was expanded to $350,000. Our financial statements, including our schedule of investments, reflected our investments in Crystal Financial on a consolidated basis. On July 28, 2016, the Company purchased Crystal Management LP’s approximately 2% equity interest in Crystal Financial LLC for approximately $5,737. Upon the closing of this transaction, the Company holds 100% of the equity interest in Crystal Financial LLC. On September 30, 2016, Crystal Capital Financial Holdings LLC was dissolved.

As of March 31, 2017 Crystal Financial LLC had 25 funded commitments to 24 different issuers with a total par value of approximately $347,108 on total assets of $465,823. As of December 31, 2016, Crystal Financial LLC had 26 funded commitments to 25 different issuers with a total par value of approximately $368,784 on total assets of $459,732. As of March 31, 2017 and December 31, 2016, the largest loan outstanding totaled $37,509 and $36,255, respectively. For the same periods, the average exposure per issuer was $14,463 and $14,751, respectively. Crystal Financial LLC’s credit facility, which is non-recourse to Solar Capital, had approximately $176,065 and $175,422 of borrowings outstanding at March 31, 2017 and December 31, 2016, respectively. For the three months ended March 31, 2017 and 2016, Crystal Financial LLC had net income of $7,839 and $9,199, respectively, on gross income of $12,260 and $15,211, respectively. Due to timing and non-cash items, there may be material differences between GAAP net income and cash available for distributions.

Note 11. Stock Repurchase Programs

On July 31, 2013, the Board authorized a program for the purpose of repurchasing up to $100,000 of the Company’s common stock. Under the repurchase program, the Company could have, but was not obligated to,

29

SOLAR CAPITAL LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2017

(in thousands, except share amounts)

repurchase its outstanding common stock in the open market from time to time provided that the Company complied with the prohibitions under its Insider Trading Policies and Procedures and the guidelines specified in Rules 10b-18 and 10b-5 under the Securities Exchange Act of 1934, as amended, including certain price, market volume and timing constraints. On December 5, 2013, the Board extended the repurchase program to be in place until the earlier of July 31, 2014 or until $100,000 of the Company’s outstanding shares of common stock had been repurchased. On July 31, 2014, the Company’s stock repurchase program expired. During the fiscal year ended December 31, 2014, the Company repurchased 1,779,033 shares at an average price of approximately $21.97 per share, inclusive of commissions. The total dollar amount of shares repurchased in that period was $39,078. During the year ended December 31, 2013, the Company repurchased 796,418 shares at an average price of approximately $21.98 per share, inclusive of commissions, for a total dollar amount of $17,508.

On October 7, 2015, the Board authorized a new share repurchase program to purchase common stock in the open market in an amount up to $30,000. Under the repurchase program, the Company may, but is not obligated to, repurchase its outstanding common stock in the open market from time to time provided that the Company complies with the prohibitions under its Insider Trading Policies and Procedures and the guidelines specified in Rules 10b-18 and 10b-5 under the Securities Exchange Act of 1934, as amended, including certain price, market volume and timing constraints. During the year ended December 31, 2016, the Company repurchased 216,237 shares at an average price of $15.76 per share, inclusive of commissions. The total dollar amount of shares repurchased for the year ended December 31, 2016 was $3,408. On October 7, 2016, the Company’s stock repurchase program expired.

Note 12. Commitments and Contingencies

The Company had unfunded debt and equity commitments to various delayed draw loans as well as to Crystal Financial LLC. The total amount of these unfunded commitments as of March 31, 2017 and December 31, 2016 is $51,662 and $64,013, respectively, comprised of the following:

	March 31, 2017		December 31, 2016
Crystal Financial LLC	$	44,263	$	44,263
aTyr Pharma, Inc		5,000		5,000
CardioFocus, Inc		2,000		—
Island Medical Management Holdings, LLC		399		—
Vapotherm, Inc		—		10,000
SentreHeart, Inc		—		2,500
Conventus Orthopaedics, Inc		—		2,250
Total Commitments*	$	51,662	$	64,013

* The Company controls the funding of the Crystal Financial LLC commitment and may cancel it at its discretion.

As of March 31, 2017 and December 31, 2016, the Company had sufficient cash available and/or liquid securities available to fund its commitments as well as the commitments to Senior Secured Unitranche Loan Program LLC (“SSLP”) disclosed in Note 13, Senior Secured Unitranche Loan Program II LLC (“SSLP II”) disclosed in Note 14 and Solar Life Science Program LLC (“LSJV”) disclosed in Note 15.

30

SOLAR CAPITAL LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2017

(in thousands, except share amounts)

Note 13. Senior Secured Unitranche Loan Program LLC

On September 2, 2014, the Company entered into a limited liability company agreement with an affiliate (the “Investor”) of a fund managed by Pacific Investment Management Company LLC (“PIMCO”) to co-invest in middle market senior secured unitranche loans sourced by the same origination platform used by the Company. Initial funding commitments to the unitranche strategy total $600,000, consisting of direct equity investments and co-investment commitments as described below. The joint venture vehicle known as the SSLP is structured as an unconsolidated Delaware limited liability company. The Company and the Investor initially made equity commitments to the SSLP of $300,000 and $43,250, respectively. All portfolio decisions and generally all other decisions in respect of the SSLP must be approved by an investment committee of the SSLP consisting of representatives of the Company and PIMCO (with approval from a representative of each required).

On October 15, 2015, the Company entered into an amended and restated limited liability company agreement for its SSLP to add Voya Investment Management LLC (“Voya”), part of Voya Financial, Inc. (NYSE: VOYA), as a partner in SSLP in place of the investor that was previously the Company’s partner in SSLP, though this investor may still co-invest up to $300,000 of equity in unitranche loans alongside SSLP. This joint venture is expected to invest primarily in senior secured loans, including unitranche loans, primarily to middle market companies predominantly owned by private equity sponsors or entrepreneurs, consistent with the Company’s core origination and underwriting mandate. In addition to the Company’s prior equity commitment of $300,000 to SSLP, Voya has made an initial equity commitment of $25,000 to SSLP, with the ability to upsize.

On November 2, 2015, the Company assigned $125,000 of its $300,000 commitment to SSLP to Senior Secured Unitranche Loan Program II LLC (“SSLP II”), a Delaware limited liability company.

On November 25, 2015, SSLP commenced operations. On June 30, 2016, SSLP as transferor and SSLP 2016-1, LLC, a newly formed wholly owned subsidiary of SSLP, as borrower entered into a $200,000 senior secured revolving credit facility (the “SSLP Facility”) with Wells Fargo Bank, NA acting as administrative agent. Solar Capital Ltd. acts as servicer under the SSLP Facility. The SSLP Facility is scheduled to mature on June 30, 2021. The SSLP Facility generally bears interest at a rate of LIBOR plus 2.50%. SSLP andSSLP 2016-1, LLC, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SSLP Facility also includes usual and customary events of default for credit facilities of this nature. There were $76,148 and $67,148 of borrowings outstanding as of March 31, 2017 and December 31, 2016, respectively. As of March 31, 2017 and December 31, 2016, the Company and Voya had contributed combined equity capital in the amount of $116,433 and $116,433, respectively. Of the $116,433 of contributed equity capital at March 31, 2017, the Company contributed $29,884 in the form of investments and $71,995 in the form of cash and Voya contributed $14,554 in the form of cash. As of March 31, 2017, the Company and Voya’s remaining commitments to SSLP totaled $73,121 and $10,446, respectively. The Company, along with Voya, controls the funding of SSLP and SSLP may not call the unfunded commitments without approval of both the Company and Voya.

As of March 31, 2017 and December 31, 2016, SSLP had total assets of $208,468 and $184,816, respectively. For the same periods, SSLP’s portfolio consisted of floating rate senior secured loans to 12 and 11 different borrowers, respectively. For the three months ended March 31, 2017, SSLP invested $24,020 in 4 portfolio companies. Investments prepaid totaled $589 for the three months ended March 31, 2017. At

31

SOLAR CAPITAL LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2017

(in thousands, except share amounts)

March 31, 2017 and December 31, 2016, the weighted average yield of SSLP’s portfolio was 7.4% and 7.4%, respectively, measured at fair value and 7.4% and 7.5%, respectively, measured at cost.

SSLP Portfolio as of March 31, 2017

Description	Industry	Spread Above Index(1)		LIBOR Floor			Interest Rate(2)			Maturity Date		Par Amount		Cost		Fair Value(3)
AccentCare, Inc.	Health Care Providers & Services		L+575		1.00	%		6.75	%		9/3/21	$	12,813	$	12,773	$	12,748
Alera Group Intermediate Holdings, Inc.	Insurance		L+550		1.00	%		6.50	%		12/30/22		13,824		13,691		13,686
Associated Pathologists, LLC	Health Care Providers & Services		L+500		1.00	%		6.04	%		8/1/21		3,208		3,180		3,196
CIBT Holdings, Inc.	Professional Services		L+525		1.00	%		6.40	%		6/28/22		13,036		12,919		12,971
Empower Payments Acquisition, Inc. (RevSpring)	Professional Services		L+550		1.00	%		6.65	%		11/30/23		13,840		13,574		13,564
Falmouth Group Holdings Corp. (AMPAC)(4)	Chemicals		L+675		1.00	%		7.75	%		12/14/21		34,563		34,133		34,563
Island Medical Management Holdings, LLC(4)	Health Care Providers & Services		L+550		1.00	%		6.50	%		9/1/22		13,812		13,674		13,674
Pet Holdings ULC & Pet Supermarket, Inc.	Specialty Retail		L+550		1.00	%		6.50	%		7/5/22		21,043		20,759		20,780
PPT Management Holdings, LLC	Health Care Providers & Services		L+600		1.00	%		7.15	%		12/16/22		11,970		11,855		11,850
PSKW, LLC & PDR, LLC	Health Care Providers & Services		L+425		1.00	%		5.40	%		11/25/21		2,406		2,387		2,406
PSKW, LLC & PDR, LLC	Health Care Providers & Services		L+836		1.00	%		9.51	%		11/25/21		22,250		21,881		21,889
U.S. Anesthesia Partners Inc.	Health Care Providers & Services		L+500		1.00	%		6.00	%		12/31/19		19,507		19,369		19,410
VetCor Professional Practices LLC	Health Care Facilities		L+600		1.00	%		7.15	%		4/20/21		23,726		23,562		23,251
														$	203,757	$	203,988

(1) Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or PRIME rate. These instruments are typically subject to a LIBOR or PRIME rate floor.

(2) Floating rate debt investments typically bear interest at a rate determined by reference to either the London Interbank Offered Rate (“LIBOR” or “L”) index rate or the prime index rate (PRIME or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of March 31, 2017.

(3) Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.

(4) The Company also holds this security on its Consolidated Statements of Assets and Liabilities.

32

SOLAR CAPITAL LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2017

(in thousands, except share amounts)

SSLP Portfolio as of December 31, 2016 (audited)

Description	Industry	Spread Above Index(1)		LIBOR Floor			Interest Rate(2)			Maturity Date		Par Amount		Cost		Fair Value(3)
AccentCare, Inc.	Health Care Providers & Services		L+575		1.00	%		6.75	%		9/3/21	$	4,875	$	4,875	$	4,875
Alera Group Intermediate Holdings, Inc.	Insurance		L+550		1.00	%		6.50	%		12/30/22		13,824		13,686		13,686
Associated Pathologists, LLC	Health Care Providers & Services		L+500		1.00	%		6.00	%		8/1/21		3,292		3,261		3,275
CIBT Holdings, Inc.	Professional Services		L+525		1.00	%		6.25	%		6/28/22		13,102		12,979		12,971
Empower Payments Acquisition, Inc. (RevSpring)	Professional Services		L+550		1.00	%		6.50	%		11/30/23		13,875		13,600		13,597
Falmouth Group Holdings Corp. (AMPAC)(4)	Chemicals		L+675		1.00	%		7.75	%		12/14/21		34,650		34,202		34,650
Pet Holdings ULC & Pet Supermarket, Inc.	Specialty Retail		L+550		1.00	%		6.50	%		7/5/22		20,625		20,336		20,367
PPT Management Holdings, LLC	Health Care Providers & Services		L+600		1.00	%		7.00	%		12/16/22		12,000		11,881		11,880
PSKW, LLC & PDR, LLC	Health Care Providers & Services		L+425		1.00	%		5.25	%		11/25/21		2,475		2,454		2,475
PSKW, LLC & PDR, LLC	Health Care Providers & Services		L+839		1.00	%		9.39	%		11/25/21		22,250		21,866		21,861
U.S. Anesthesia Partners Inc.	Health Care Providers & Services		L+500		1.00	%		6.00	%		12/31/19		19,557		19,407		19,362
VetCor Professional Practices LLC	Health Care Facilities		L+625		1.00	%		7.25	%		4/20/21		21,818		21,686		21,491
														$	180,233	$	180,490

(1) Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or PRIME rate. These instruments are typically subject to a LIBOR or PRIME rate floor.

(2) Floating rate debt investments typically bear interest at a rate determined by reference to either the London Interbank Offered Rate (“LIBOR” or “L”) index rate or the prime index rate (PRIME or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2016.

(3) Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.

(4) The Company also holds this security on its Consolidated Statements of Assets and Liabilities.

Below is certain summarized financial information for SSLP as of March 31, 2017 and December 31, 2016 and for the three months ended March 31, 2017 and 2016:

	March 31, 2017		December 31, 2016 (audited)
Selected Balance Sheet Information for SSLP:
Investments at fair value (cost $203,757 and $180,233, respectively)	$	203,988	$	180,490
Cash and other assets		4,480		4,326
Total assets	$	208,468	$	184,816
Debt outstanding	$	76,148	$	67,148
Payable for investments purchased		13,674		—
Distributions payable		2,427		1,688
Interest payable and other credit facility related expenses		781		660
Accrued expenses and other payables		260		287
Total liabilities	$	93,290	$	69,783
Members’ equity	$	115,178	$	115,033
Total liabilities and members’ equity	$	208,468	$	184,816

33

SOLAR CAPITAL LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2017

(in thousands, except share amounts)

	Three months ended March 31, 2017			Three months ended March 31, 2016
Selected Income Statement Information for SSLP:
Interest income	$	3,447		$	1,846
Service fees*	$	31		$	15
Interest and other credit facility expenses		781			—
Other general and administrative expenses		37			35
Total expenses	$	849		$	50
Net investment income	$	2,598		$	1,796
Net change in unrealized gain (loss) on investments		(26	)		(717	)
Net income	$	2,572		$	1,079

* Service fees are included within the Company’s Consolidated Statements of Operations as other income.

Note 14. Senior Secured Unitranche Loan Program II LLC

On November 2, 2015, the Company assigned $125,000 of its $300,000 commitment to SSLP to SSLP II, a Delaware limited liability company. On August 5, 2016, the Company entered into an amended and restated limited liability company agreement with WFI Loanco, LLC (“WFI”) and SSLP II commenced operations. SSLP II is expected to invest primarily in senior secured loans, including unitranche loans, primarily to middle market companies predominantly owned by private equity sponsors or entrepreneurs, consistent with the Company’s core origination and underwriting mandate. Also on August 5, 2016, the Company assigned $49,977 of its $125,000 commitment to SSLP II to Senior Secured Unitranche Loan Program III LLC (“SSLP III”), a newly formed Delaware limited liability company. SSLP III, which has not commenced operations, is currently wholly owned by Solar Capital Ltd. but may bring in unaffiliated investors at a later date. The Company and WFI’s equity commitments to SSLP II now total $75,023 and $18,000, respectively.

On November 15, 2016, SSLP II as transferor and SSLP II 2016-1, LLC, a newly formed wholly owned subsidiary of SSLP II, as borrower entered into a $100,000 senior secured revolving credit facility (the “SSLP II Facility”) with Wells Fargo Bank, NA acting as administrative agent. Solar Capital Ltd. acts as servicer under the SSLP II Facility. The SSLP II Facility is scheduled to mature on November 15, 2021. The SSLP II Facility generally bears interest at a rate of LIBOR plus 2.50%. SSLP II and SSLP II 2016-1, LLC, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SSLP II Facility also includes usual and customary events of default for credit facilities of this nature. There were $45,250 and $32,950 of borrowings outstanding as of March 31, 2017 and December 31, 2016, respectively. As of March 31, 2017 and December 31, 2016, the Company and WFI contributed combined equity capital in the amount of $59,231 and $58,231, respectively. Of the $59,231 of contributed equity capital at March 31, 2017, the Company contributed $43,498 in the form of investments and $4,272 in the form of cash and WFI contributed $11,461 in the form of cash. As of March 31, 2017, the Company and WFI’s remaining commitments to SSLP II totaled $27,253 and $6,539, respectively. The Company, along with WFI, controls the funding of SSLP II and SSLP II may not call the unfunded commitments without approval of both the Company and WFI.

34

SOLAR CAPITAL LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2017

(in thousands, except share amounts)

As of March 31, 2017 and December 31, 2016, SSLP II had total assets of $114,369 and $93,467, respectively. For the same periods, SSLP II’s portfolio consisted of floating rate senior secured loans to 15 and 12 different borrowers, respectively. For the three months ended March 31, 2017, SSLP II invested $19,987 in 5 portfolio companies. Investments prepaid totaled $953 for the same period. At March 31, 2017 and December 31, 2016, the weighted average yield of SSLP II’s portfolio was 7.3% and 7.6%, respectively, measured at fair value and 7.7% and 7.9%, respectively, measured at cost.

SSLP II Portfolio as of March 31, 2017

Description	Industry	Spread Above Index(1)		LIBOR Floor			Interest Rate(2)			Maturity Date		Par Amount		Cost		Fair Value(3)
AccentCare, Inc.	Health Care Providers & Services		L+575		1.00	%		6.75	%		9/3/21	$	7,000	$	6,965	$	6,965
Alera Group Intermediate Holdings, Inc.	Insurance		L+550		1.00	%		6.50	%		12/30/22		5,184		5,134		5,132
American Teleconferencing Services, Ltd. (PGI)(4)	Communications Equipment		L+650		1.00	%		7.50	%		12/8/21		14,429		13,126		14,357
Associated Pathologists, LLC	Health Care Providers & Services		L+500		1.00	%		6.04	%		8/1/21		1,604		1,590		1,598
CIBT Holdings, Inc.	Professional Services		L+525		1.00	%		6.40	%		6/28/22		5,214		5,167		5,188
Empower Payments Acquisition, Inc. (RevSpring)	Professional Services		L+550		1.00	%		6.65	%		11/30/23		6,920		6,787		6,782
Falmouth Group Holdings Corp. (AMPAC)(4)	Chemicals		L+675		1.00	%		7.75	%		12/14/21		10,917		10,917		10,917
Island Medical Management Holdings, LLC(4)	Health Care Providers & Services		L+550		1.00	%		6.50	%		9/1/22		6,906		6,837		6,837
Pet Holdings ULC & Pet Supermarket, Inc.	Specialty Retail		L+550		1.00	%		6.50	%		7/5/22		9,259		9,132		9,143
Polycom, Inc.	Communications Equipment		L+525		1.00	%		6.25	%		9/27/23		11,050		10,631		11,050
PPT Management Holdings, LLC	Health Care Providers & Services		L+600		1.00	%		7.15	%		12/16/22		9,975		9,879		9,875
Professional DataSolutions, Inc.	Software		L+550		1.00	%		6.50	%		5/20/22		5,000		4,925		4,925
PSKW, LLC & PDR, LLC	Health Care Providers & Services		L+425		1.00	%		5.40	%		11/25/21		963		963		963
PSKW, LLC & PDR, LLC	Health Care Providers & Services		L+836		1.00	%		9.51	%		11/25/21		8,900		8,754		8,756
U.S. Anesthesia Partners Inc.	Health Care Providers & Services		L+500		1.00	%		6.00	%		12/31/19		4,975		4,930		4,950
VetCor Professional Practices LLC	Health Care Facilities		L+600		1.00	%		7.15	%		4/20/21		3,910		3,839		3,832
														$	109,576	$	111,270

(1) Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or PRIME rate. These instruments are typically subject to a LIBOR or PRIME rate floor.

(2) Floating rate debt investments typically bear interest at a rate determined by reference to either the London Interbank Offered Rate (“LIBOR” or “L”) index rate or the prime index rate (PRIME or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of March 31, 2017.

(3) Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.

(4) The Company also holds this security on its Consolidated Statements of Assets and Liabilities.

35

SOLAR CAPITAL LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2017

(in thousands, except share amounts)

SSLP II Portfolio as of December 31, 2016 (audited)

Description	Industry	Spread Above Index(1)		LIBOR Floor			Interest Rate(2)			Maturity Date		Par Amount		Cost		Fair Value(3)
Alera Group Intermediate Holdings, Inc.	Insurance		L+550		1.00	%		6.50	%		12/30/22	$	5,184	$	5,132	$	5,132
American Teleconferencing Services, Ltd. (PGI)(4)	Communications Equipment		L+650		1.00	%		7.50	%		12/8/21		14,619		13,244		14,217
Associated Pathologists, LLC	Health Care Providers & Services		L+500		1.00	%		6.00	%		8/1/21		1,646		1,631		1,638
CIBT Holdings, Inc.	Professional Services		L+525		1.00	%		6.25	%		6/28/22		5,241		5,191		5,188
Empower Payments Acquisition, Inc. (RevSpring)	Professional Services		L+550		1.00	%		6.50	%		11/30/23		6,938		6,800		6,799
Falmouth Group Holdings Corp. (AMPAC)(4)	Chemicals		L+675		1.00	%		7.75	%		12/14/21		10,945		10,945		10,945
Pet Holdings ULC & Pet Supermarket, Inc.	Specialty Retail		L+550		1.00	%		6.50	%		7/5/22		9,075		8,947		8,962
Polycom, Inc.	Communications Equipment		L+650		1.00	%		7.50	%		9/27/23		11,605		11,152		11,547
PPT Management Holdings, LLC	Health Care Providers & Services		L+600		1.00	%		7.00	%		12/16/22		10,000		9,901		9,900
PSKW, LLC & PDR, LLC	Health Care Providers & Services		L+425		1.00	%		5.25	%		11/25/21		990		990		990
PSKW, LLC & PDR, LLC	Health Care Providers & Services		L+839		1.00	%		9.39	%		11/25/21		8,900		8,748		8,744
U.S. Anesthesia Partners Inc.	Health Care Providers & Services		L+500		1.00	%		6.00	%		12/31/19		4,988		4,938		4,938
VetCor Professional Practices LLC	Health Care Facilities		L+625		1.00	%		7.25	%		4/20/21		2,840		2,787		2,797
														$	90,406	$	91,797

(1) Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or PRIME rate. These instruments are typically subject to a LIBOR or PRIME rate floor.

(2) Floating rate debt investments typically bear interest at a rate determined by reference to either the London Interbank Offered Rate (“LIBOR” or “L”) index rate or the prime index rate (PRIME or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2016.

(3) Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.

(4) The Company also holds this security on its Consolidated Statements of Assets and Liabilities.

Below is certain summarized financial information for SSLP II as of March 31, 2017 and December 31, 2016 and for the three months ended March 31, 2017:

	March 31, 2017		December 31, 2016 (audited)
Selected Balance Sheet Information for SSLP II:
Investments at fair value (cost $109,576 and $90,406, respectively)	$	111,270	$	91,797
Cash and other assets		3,099		1,670
Total assets	$	114,369	$	93,467
Debt outstanding	$	45,250	$	32,950
Payable for investments purchased		6,837		—
Distributions payable		1,463		1,460
Interest payable and other credit facility related expenses		405		147
Accrued expenses and other payables		223		183
Total liabilities	$	54,178	$	34,740
Members’ equity	$	60,191	$	58,727
Total liabilities and members’ equity	$	114,369	$	93,467

36

SOLAR CAPITAL LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)

March 31, 2017

(in thousands, except share amounts)

	Three months ended March 31, 2017
Selected Income Statement Information for SSLP II:
Interest income	$	2,091
Service fees*	$	24
Interest and other credit facility expenses		418
Other general and administrative expenses		25
Total expenses	$	467
Net investment income	$	1,624
Net change in unrealized gain on investments		303
Net income	$	1,927

* Service fees are included within the Company’s Consolidated Statements of Operations as other income.

Note 15. Solar Life Science Program LLC

On February 22, 2017, the Company, through its commitment to SSLP III, and Solar Senior Capital Ltd. formed LSJV with an affiliate of Deerfield Management. SSLP III committed approximately $49,977 to LSJV. As of March 31, 2017, LSJV has not commenced operations.

Note 16. Capital Share Transactions

As of March 31, 2017 and December 31, 2016, 200,000,000 shares of $0.01 par value capital stock were authorized.

Transactions in capital stock were as follows:

	Shares				Amount
	Three months ended March 31, 2017		Year ended December 31, 2016		Three months ended March 31, 2017		Year ended December 31, 2016
Repurchases of common stock		—		216,237	$	—	$	3,408

On May 2, 2017, our Board declared a quarterly distribution of $0.40 per share payable on July 5, 2017 to holders of record as of June 22, 2017.

Note 17. Subsequent Events

The Company has evaluated the need for disclosures and/or adjustments resulting from subsequent events through the date the consolidated financial statements were issued.

On May 2, 2017, our Board declared a quarterly distribution of $0.40 per share payable on July 5, 2017 to holders of record as of June 22, 2017.

37

Report of Independent Registered Public Accounting Firm

The Board of Directors and Stockholders

Solar Capital Ltd.:

We have reviewed the accompanying consolidated statement of assets and liabilities, including the consolidated schedule of investments, of Solar Capital Ltd. (the “Company”) as of March 31, 2017, the related consolidated statements of operations for the three-month periods ended March 31, 2017 and 2016, the related consolidated statement of changes in net assets for the three-month period ended March 31, 2017, and the related consolidated statements of cash flows for the three-month periods ended March 31, 2017 and 2016. These consolidated financial statements are the responsibility of the Company’s management.

We conducted our review in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States), the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

Based on our review, we are not aware of any material modifications that should be made to the consolidated financial statements referred to above for them to be in conformity with U.S. generally accepted accounting principles.

We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated statement of assets and liabilities, including the consolidated schedule of investments, of Solar Capital Ltd., as of December 31, 2016 and the related consolidated statements of operations, changes in net assets, and cash flows for the year ended December 31, 2016, and in our report dated February 22, 2017, we expressed an unqualified opinion on those consolidated financial statements.

/s/ KPMG LLP

New York, New York

May 2, 2017

38

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The information contained in this section should be read in conjunction with our consolidated financial statements and notes thereto appearing elsewhere in this report.

Some of the statements in this report constitute forward-looking statements, which relate to future events or our future performance or financial condition. The forward-looking statements contained herein involve risks and uncertainties, including statements as to:

• our future operating results;

• our business prospects and the prospects of our portfolio companies;

• the impact of investments that we expect to make;

• our contractual arrangements and relationships with third parties;

• the dependence of our future success on the general economy and its impact on the industries in which we invest;

• the ability of our portfolio companies to achieve their objectives;

• our expected financings and investments;

• the adequacy of our cash resources and working capital; and

• the timing of cash flows, if any, from the operations of our portfolio companies.

We generally use words such as “anticipates,” “believes,” “expects,” “intends” and similar expressions to identify forward-looking statements. Our actual results could differ materially from those projected in the forward-looking statements for any reason, including any factors set forth in “Risk Factors” and elsewhere in this report.

We have based the forward-looking statements included in this report on information available to us on the date of this report, and we assume no obligation to update any such forward-looking statements. Although we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, you are advised to consult any additional disclosures that we may make directly to you or through reports that we in the future may file with the SEC, including any annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.

Overview

Solar Capital LLC, a Maryland limited liability company, was formed in February 2007 and commenced operations on March 13, 2007 with initial capital of $1.2 billion of which 47.04% was funded by affiliated parties.

Solar Capital Ltd. (“Solar Capital”, the “Company”, “we” or “our”), a Maryland corporation formed in November 2007, is a closed-end, externally managed, non-diversified management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). Furthermore, as the Company is an investment company, it continues to apply the guidance in the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946. In addition, for tax purposes, the Company has elected to be treated as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).

On February 9, 2010, we priced our initial public offering, selling 5.68 million shares of our common stock. Concurrent with our initial public offering, Michael S. Gross, our Chairman and Chief Executive Officer, and

39

Bruce Spohler, our Chief Operating Officer, collectively purchased an additional 0.6 million shares of our common stock through a private placement transaction exempt from registration under the Securities Act (the “Concurrent Private Placement”).

We invest primarily in privately held U.S. middle-market companies, where we believe the supply of primary capital is limited and the investment opportunities are most attractive. Our investment objective is to generate both current income and capital appreciation through debt and equity investments. We invest primarily in leveraged middle-market companies in the form of senior secured loans, unitranche loans, mezzanine loans and equity securities. From time to time, we may also invest in public companies that are thinly traded. Our business is focused primarily on the direct origination of investments through portfolio companies or their financial sponsors. Our investments generally range between $5 million and $100 million each, although we expect that this investment size will vary proportionately with the size of our capital base and/or with strategic initiatives. Our investment activities are managed by Solar Capital Partners, LLC (the “Investment Adviser”) and supervised by our board of directors, a majority of whom are non-interested, as such term is defined in the 1940 Act. Solar Capital Management, LLC (the “Administrator”) provides the administrative services necessary for us to operate.

In addition, we may invest a portion of our portfolio in other types of investments, which we refer to as opportunistic investments, which are not our primary focus but are intended to enhance our overall returns. These investments may include, but are not limited to, direct investments in public companies that are not thinly traded and securities of leveraged companies located in select countries outside of the United States.

As of March 31, 2017, the Investment Adviser has directly invested approximately $6.2 billion in more than 270 different portfolio companies since 2006. Over the same period, the Investment Adviser completed transactions with more than 165 different financial sponsors.

Recent Developments

On May 2, 2017, our Board declared a quarterly distribution of $0.40 per share payable on July 5, 2017 to holders of record as of June 22, 2017.

Investments

Our level of investment activity can and does vary substantially from period to period depending on many factors, including the amount of debt and equity capital available to middle market companies, the level of merger and acquisition activity for such companies, the general economic environment and the competitive environment for the types of investments we make. As a BDC, we must not acquire any assets other than “qualifying assets” specified in the 1940 Act unless, at the time the acquisition is made, at least 70% of our total assets are qualifying assets (with certain limited exceptions). Qualifying assets include investments in “eligible portfolio companies.” The definition of “eligible portfolio company” includes certain public companies that do not have any securities listed on a national securities exchange and companies whose securities are listed on a national securities exchange but whose market capitalization is less than $250 million.

Revenue

We generate revenue primarily in the form of interest and dividend income from the securities we hold and capital gains, if any, on investment securities that we may sell. Our debt investments generally have a stated term of three to seven years and typically bear interest at a floating rate usually determined on the basis of a benchmark London interbank offered rate (“LIBOR”), commercial paper rate, or the prime rate. Interest on our debt investments is generally payable quarterly but may be monthly or semi-annually. In addition, our investments may provide payment-in-kind (“PIK”) interest. Such amounts of accrued PIK interest are added to the cost of the investment on the respective capitalization dates and generally become due at maturity of the

40

investment or upon the investment being called by the issuer. We may also generate revenue in the form of commitment, origination, structuring fees, fees for providing managerial assistance and, if applicable, consulting fees, etc.

Expenses

All investment professionals of the investment adviser and their respective staffs, when and to the extent engaged in providing investment advisory and management services, and the compensation and routine overhead expenses of such personnel allocable to such services, are provided and paid for by Solar Capital Partners. We bear all other costs and expenses of our operations and transactions, including (without limitation):

• the cost of our organization and public offerings;

• the cost of calculating our net asset value, including the cost of any third-party valuation services;

• the cost of effecting sales and repurchases of our shares and other securities;

• interest payable on debt, if any, to finance our investments;

• fees payable to third parties relating to, or associated with, making investments, including fees and expenses associated with performing due diligence reviews of prospective investments and advisory fees;

• transfer agent and custodial fees;

• fees and expenses associated with marketing efforts;

• federal and state registration fees, any stock exchange listing fees;

• federal, state and local taxes;

• independent directors’ fees and expenses;

• brokerage commissions;

• fidelity bond, directors and officers errors and omissions liability insurance and other insurance premiums;

• direct costs and expenses of administration, including printing, mailing, long distance telephone and staff;

• fees and expenses associated with independent audits and outside legal costs;

• costs associated with our reporting and compliance obligations under the 1940 Act and applicable federal and state securities laws; and

• all other expenses incurred by either Solar Capital Management or us in connection with administering our business, including payments under the Administration Agreement that will be based upon our allocable portion of overhead and other expenses incurred by Solar Capital Management in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing compliance functions, and our allocable portion of the costs of compensation and related expenses of our chief compliance officer and our chief financial officer and any administrative support staff.

We expect our general and administrative operating expenses related to our ongoing operations to increase moderately in dollar terms. During periods of asset growth, we generally expect our general and administrative operating expenses to decline as a percentage of our total assets and increase during periods of asset declines. Incentive fees, interest expense and costs relating to future offerings of securities, among others, may also increase or reduce overall operating expenses based on portfolio performance, interest rate benchmarks, and offerings of our securities relative to comparative periods, among other factors.

41

Portfolio and Investment Activity

During the three months ended March 31, 2017, we invested approximately $99.6 million across 11 portfolio companies. This compares to investing approximately $42.8 million in 6 portfolio companies for the three months ended March 31, 2016. Investments sold, prepaid or repaid during the three months ended March 31, 2017 totaled approximately $84.7 million versus approximately $30.6 million for the three months ended March 31, 2016.

At March 31, 2017, our portfolio consisted of 61 portfolio companies and was invested 61.0% in senior secured loans, 2.1% in subordinated debt, 1.1% in preferred equity and 35.8% in common equity/equity interests and warrants (of which 23.1% is Crystal Financial LLC, 7.6% is Senior Secured Unitranche Loan Program LLC and 3.7% is Senior Secured Unitranche Loan Program II LLC) measured at fair value versus 56 portfolio companies invested 63.4% in senior secured loans, 5.5% in subordinated debt, 1.3% in preferred equity and 29.8% in common equity/equity interests and warrants (of which 21.9% is Crystal Financial LLC and 6.1% is Senior Secured Unitranche Loan Program LLC) measured at fair value at March 31, 2016.

At March 31, 2017, 96.4% or $1,257.1 million of our income producing investment portfolio* is floating rate and 3.6% or $47.0 million is fixed rate, measured at fair value. At March 31, 2016, 90.7% or $1,191.1 million of our income producing investment portfolio^* was floating rate and 9.3% or $121.4 million was fixed rate, measured at fair value. As of both March 31, 2017 and 2016, we had one issuer on non-accrual status.

Since inception through March 31, 2017, Solar Capital and its predecessor companies have invested approximately $4.9 billion in 171 portfolio companies. Over the same period, Solar Capital has completed transactions with more than 125 different financial sponsors.

Crystal Financial LLC

On December 28, 2012, we completed the acquisition of Crystal Capital Financial Holdings LLC (“Crystal Financial”), a commercial finance company focused on providing asset-based and other secured financing solutions (the “Crystal Acquisition”). We invested $275 million in cash to effect the Crystal Acquisition. Crystal Financial owned approximately 98% of the outstanding ownership interest in Crystal Financial LLC. The remaining financial interest was held by various employees of Crystal Financial LLC, through their investment in Crystal Management LP. Crystal Financial LLC had a diversified portfolio of 23 loans having a total par value of approximately $400 million at November 30, 2012 and a $275 million committed revolving credit facility. On January 27, 2014, the revolving credit facility was expanded to $300 million. On March 31, 2014, we exchanged $137.5 million of our equity interest in Crystal Financial in exchange for $137.5 million in floating rate senior secured notes in Crystal Financial bearing interest at LIBOR plus 9.50%, maturing on March 31, 2019. On May 18, 2015, the revolving credit facility was expanded to $350 million. Our financial statements, including our schedule of investments, reflected our investments in Crystal Financial on a consolidated basis. On July 28, 2016, the Company purchased Crystal Management LP’s approximately 2% equity interest in Crystal Financial LLC for approximately $5.7 million. Upon the closing of this transaction, the Company holds 100% of the equity interest in Crystal Financial LLC. On September 30, 2016, Crystal Capital Financial Holdings LLC was dissolved.

As of March 31, 2017, Crystal Financial LLC had 25 funded commitments to 24 different issuers with a total par value of approximately $347.1 million on total assets of $465.8 million. As of December 31, 2016, Crystal Financial LLC had 26 funded commitments to 25 different issuers with a total par value of approximately $368.8 million on total assets of $459.7 million. As of March 31, 2017 and December 31, 2016, the largest loan outstanding totaling $37.5 million and $36.3 million, respectively. For the same periods, the average exposure per issuer was $14.5 million and $14.8 million, respectively. Crystal Financial LLC’s credit facility, which is

* We have included Crystal Financial LLC, Senior Secured Unitranche Loan Program LLC and Senior Secured Unitranche Loan Program II LLC within our income producing investment portfolio.

42

non-recourse to Solar Capital, had approximately $176.1 million and $175.4 million of borrowings outstanding at March 31, 2017 and December 31, 2016, respectively. For the three months ended March 31, 2017 and March 31, 2016, Crystal Financial LLC had net income of $7.8 million and $9.2 million, respectively, on gross income of $12.3 million and $15.2 million, respectively. Due to timing and non-cash items, there may be material differences between GAAP net income and cash available for distributions. As of March 31, 2017, and based upon our expectations for Crystal Financial LLC’s portfolio performance, we believe that Crystal Financial LLC will be able to maintain its dividend payments to the Company.

Senior Secured Unitranche Loan Program LLC

On September 2, 2014, the Company entered into a limited liability company agreement with an affiliate (the “Investor”) of a fund managed by Pacific Investment Management Company LLC (“PIMCO”) to co-invest in middle market senior secured unitranche loans sourced by the same origination platform used by the Company. Initial funding commitments to the unitranche strategy total $600 million, consisting of direct equity investments and co-investment commitments as described below. The joint venture vehicle known as the Senior Secured Unitranche Loan Program LLC (“SSLP”) is structured as an unconsolidated Delaware limited liability company. The Company and the Investor initially made equity commitments to the SSLP of $300.0 million and $43.25 million, respectively. All portfolio decisions and generally all other decisions in respect of the SSLP must be approved by an investment committee of the SSLP consisting of representatives of the Company and PIMCO (with approval from a representative of each required).

On October 15, 2015, the Company entered into an amended and restated limited liability company agreement for its SSLP to add Voya Investment Management LLC (“Voya”), part of Voya Financial, Inc. (NYSE: VOYA), as a partner in SSLP in place of the investor that was previously the Company’s partner in SSLP, though this investor may still co-invest up to $300 million of equity in unitranche loans alongside SSLP. This joint venture is expected to invest primarily in senior secured loans, including unitranche loans, primarily to middle market companies predominantly owned by private equity sponsors or entrepreneurs, consistent with the Company’s core origination and underwriting mandate. In addition to the Company’s prior equity commitment of $300.0 million to SSLP, Voya has made an initial equity commitment of $25.0 million to SSLP, with the ability to upsize.

On November 2, 2015, the Company assigned $125.0 million of its $300.0 million commitment to SSLP to Senior Secured Unitranche Loan Program II LLC (“SSLP II”), a Delaware limited liability company.

On November 25, 2015, SSLP commenced operations. On June 30, 2016, SSLP as transferor and SSLP 2016-1, LLC, a newly formed wholly owned subsidiary of SSLP, as borrower entered into a $200 million senior secured revolving credit facility (the “SSLP Facility”) with Wells Fargo Bank, NA acting as administrative agent. Solar Capital Ltd. acts as servicer under the SSLP Facility. The SSLP Facility is scheduled to mature on June 30, 2021. The SSLP Facility generally bears interest at a rate of LIBOR plus 2.50%. SSLP andSSLP 2016-1, LLC, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SSLP Facility also includes usual and customary events of default for credit facilities of this nature. There were $76.1 million and $67.1 million of borrowings outstanding as of March 31, 2017 and December 31, 2016, respectively. As of March 31, 2017 and December 31, 2016, the Company and Voya had contributed combined equity capital in the amount of $116.4 million and $116.4 million, respectively. Of the $116.4 million of contributed equity capital at March 31, 2017, the Company contributed $29.9 million in the form of investments and $72.0 million in the form of cash and Voya contributed $14.5 million in the form of cash. As of March 31, 2017, the Company and Voya’s remaining commitments to SSLP totaled $73.1 million and $10.5 million, respectively. The Company, along with Voya, controls the funding of SSLP and SSLP may not call the unfunded commitments without approval of both the Company and Voya.

As of March 31, 2017 and December 31, 2016, SSLP had total assets of $208.5 million and $184.8 million, respectively. For the same periods, SSLP’s portfolio consisted of floating rate senior secured loans to 12 and 11

43

different borrowers, respectively. For the three months ended March 31, 2017 and 2016, SSLP invested $24.0 million in 4 portfolio companies and $1.0 million in 1 portfolio company, respectively. Investments prepaid totaled $0.6 million and $0.2 million, respectively, for the three months ended March 31, 2017 and 2016. At March 31, 2017 and December 31, 2016, the weighted average yield of SSLP’s portfolio was 7.4% and 7.4%, respectively, measured at fair value and 7.4% and 7.5%, respectively, measured at cost.

SSLP Portfolio as of March 31, 2017 (in thousands)

Description	Industry	Spread Above Index(1)		LIBOR Floor			Interest Rate(2)			Maturity Date		Par Amount		Cost		Fair Value(3)
AccentCare, Inc.	Health Care Providers & Services		L+575		1.00	%		6.75	%		9/3/21	$	12,813	$	12,773	$	12,748
Alera Group Intermediate Holdings, Inc.	Insurance		L+550		1.00	%		6.50	%		12/30/22		13,824		13,691		13,686
Associated Pathologists, LLC	Health Care Providers & Services		L+500		1.00	%		6.04	%		8/1/21		3,208		3,180		3,196
CIBT Holdings, Inc.	Professional Services		L+525		1.00	%		6.40	%		6/28/22		13,036		12,919		12,971
Empower Payments Acquisition, Inc. (RevSpring)	Professional Services		L+550		1.00	%		6.65	%		11/30/23		13,840		13,574		13,564
Falmouth Group Holdings Corp. (AMPAC)(4)	Chemicals		L+675		1.00	%		7.75	%		12/14/21		34,563		34,133		34,563
Island Medical Management Holdings, LLC(4)	Health Care Providers & Services		L+550		1.00	%		6.50	%		9/1/22		13,812		13,674		13,674
Pet Holdings ULC & Pet Supermarket, Inc.	Specialty Retail		L+550		1.00	%		6.50	%		7/5/22		21,043		20,759		20,780
PPT Management Holdings, LLC	Health Care Providers & Services		L+600		1.00	%		7.15	%		12/16/22		11,970		11,855		11,850
PSKW, LLC & PDR, LLC	Health Care Providers & Services		L+425		1.00	%		5.40	%		11/25/21		2,406		2,387		2,406
PSKW, LLC & PDR, LLC	Health Care Providers & Services		L+836		1.00	%		9.51	%		11/25/21		22,250		21,881		21,889
U.S. Anesthesia Partners Inc.	Health Care Providers & Services		L+500		1.00	%		6.00	%		12/31/19		19,507		19,369		19,410
VetCor Professional Practices LLC	Health Care Facilities		L+600		1.00	%		7.15	%		4/20/21		23,726		23,562		23,251
														$	203,757	$	203,988

(1) Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or PRIME rate. These instruments are typically subject to a LIBOR or PRIME rate floor.

(2) Floating rate debt investments typically bear interest at a rate determined by reference to either the London Interbank Offered Rate (“LIBOR” or “L”) index rate or the prime index rate (PRIME or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of March 31, 2017.

(3) Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.

(4) The Company also holds this security on its Consolidated Statements of Assets and Liabilities.

44

SSLP Portfolio as of December 31, 2016 (audited) (in thousands)

Description	Industry	Spread Above Index(1)		LIBOR Floor			Interest Rate(2)			Maturity Date		Par Amount		Cost		Fair Value(3)
AccentCare, Inc.	Health Care Providers & Services		L+575		1.00	%		6.75	%		9/3/21	$	4,875	$	4,875	$	4,875
Alera Group Intermediate Holdings, Inc.	Insurance		L+550		1.00	%		6.50	%		12/30/22		13,824		13,686		13,686
Associated Pathologists, LLC	Health Care Providers & Services		L+500		1.00	%		6.00	%		8/1/21		3,292		3,261		3,275
CIBT Holdings, Inc.	Professional Services		L+525		1.00	%		6.25	%		6/28/22		13,102		12,979		12,971
Empower Payments Acquisition, Inc. (RevSpring)	Professional Services		L+550		1.00	%		6.50	%		11/30/23		13,875		13,600		13,597
Falmouth Group Holdings Corp. (AMPAC)(4)	Chemicals		L+675		1.00	%		7.75	%		12/14/21		34,650		34,202		34,650
Pet Holdings ULC & Pet Supermarket, Inc.	Specialty Retail		L+550		1.00	%		6.50	%		7/5/22		20,625		20,336		20,367
PPT Management Holdings, LLC	Health Care Providers & Services		L+600		1.00	%		7.00	%		12/16/22		12,000		11,881		11,880
PSKW, LLC & PDR, LLC	Health Care Providers & Services		L+425		1.00	%		5.25	%		11/25/21		2,475		2,454		2,475
PSKW, LLC & PDR, LLC	Health Care Providers & Services		L+839		1.00	%		9.39	%		11/25/21		22,250		21,866		21,861
U.S. Anesthesia Partners Inc.	Health Care Providers & Services		L+500		1.00	%		6.00	%		12/31/19		19,557		19,407		19,362
VetCor Professional Practices LLC	Health Care Facilities		L+625		1.00	%		7.25	%		4/20/21		21,818		21,686		21,491
														$	180,233	$	180,490

(1) Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or PRIME rate. These instruments are typically subject to a LIBOR or PRIME rate floor.

(2) Floating rate debt investments typically bear interest at a rate determined by reference to either the London Interbank Offered Rate (“LIBOR” or “L”) index rate or the prime index rate (PRIME or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2016.

(3) Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.

(4) The Company also holds this security on its Consolidated Statements of Assets and Liabilities.

Below is certain summarized financial information for SSLP as of March 31, 2017 and December 31, 2016 and for the three months ended March 31, 2017 and 2016:

	March 31, 2017		December 31, 2016 (audited)
Selected Balance Sheet Information for SSLP (in thousands):
Investments at fair value (cost $203,757 and $180,233, respectively)	$	203,988	$	180,490
Cash and other assets		4,480		4,326
Total assets	$	208,468	$	184,816
Debt outstanding	$	76,148	$	67,148
Payable for investments purchased		13,674		—
Distributions payable		2,427		1,688
Interest payable and other credit facility related expenses		781		660
Accrued expenses and other payables		260		287
Total liabilities	$	93,290	$	69,783
Members’ equity	$	115,178	$	115,033
Total liabilities and members’ equity	$	208,468	$	184,816

45

	Three months ended March 31, 2017			Three months ended March 31, 2016
Selected Income Statement Information for SSLP (in thousands):
Interest income	$	3,447		$	1,846
Service fees*	$	31		$	15
Interest and other credit facility expenses		781			—
Other general and administrative expenses		37			35
Total expenses	$	849		$	50
Net investment income	$	2,598		$	1,796
Net change in unrealized gain (loss) on investments		(26	)		(717	)
Net income	$	2,572		$	1,079

* Service fees are included within the Company’s Consolidated Statements of Operations as other income.

Senior Secured Unitranche Loan Program II LLC

On November 2, 2015, the Company assigned $125.0 million of its $300.0 million commitment to SSLP to SSLP II, a Delaware limited liability company. On August 5, 2016, the Company entered into an amended and restated limited liability company agreement with WFI Loanco, LLC (“WFI”) and SSLP II commenced operations. SSLP II is expected to invest primarily in senior secured loans, including unitranche loans, primarily to middle market companies predominantly owned by private equity sponsors or entrepreneurs, consistent with the Company’s core origination and underwriting mandate. Also on August 5, 2016, the Company assigned approximately $50.0 million of its $125.0 million commitment to SSLP II to Senior Secured Unitranche Loan Program III LLC (“SSLP III”), a newly formed Delaware limited liability company. SSLP III, which has not commenced operations, is currently wholly owned by Solar Capital Ltd. but may bring in unaffiliated investors at a later date. The Company and WFI’s equity commitments to SSLP II now total $75.0 million and $18.0 million, respectively.

On November 15, 2016, SSLP II as transferor and SSLP II 2016-1, LLC, a newly formed wholly owned subsidiary of SSLP II, as borrower entered into a $100 million senior secured revolving credit facility (the “SSLP II Facility”) with Wells Fargo Bank, NA acting as administrative agent. Solar Capital Ltd. acts as servicer under the SSLP II Facility. The SSLP II Facility is scheduled to mature on November 15, 2021. The SSLP II Facility generally bears interest at a rate of LIBOR plus 2.50%. SSLP II and SSLP II 2016-1, LLC, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SSLP II Facility also includes usual and customary events of default for credit facilities of this nature. There were $45.3 million and $33.0 million of borrowings outstanding as of March 31, 2017 and December 31, 2016, respectively. As of March 31, 2017 and December 31, 2016, the Company and WFI contributed combined equity capital in the amount of $59.2 million and $58.2 million, respectively. Of the $59.2 million of contributed equity capital at March 31, 2017, the Company contributed $43.5 million in the form of investments and $4.3 million in the form of cash and WFI contributed $11.4 million in the form of cash. As of March 31, 2017, the Company and WFI’s remaining commitments to SSLP II totaled $27.2 million and $6.5 million, respectively. The Company, along with WFI, controls the funding of SSLP II and SSLP II may not call the unfunded commitments without approval of both the Company and WFI.

As of March 31, 2017 and December 31, 2016, SSLP II had total assets of $114.4 million and $93.5 million, respectively. For the same periods, SSLP II’s portfolio consisted of floating rate senior secured loans to 15 and 12 different borrowers, respectively. For the three months ended March 31, 2017, SSLP II invested $20.0 million in 5 portfolio companies. Investments prepaid totaled $1.0 million for the same period. At March 31, 2017 and

46

December 31, 2016, the weighted average yield of SSLP II’s portfolio was 7.3% and 7.6%, respectively, measured at fair value and 7.7% and 7.9%, respectively, measured at cost.

SSLP II Portfolio as of March 31, 2017 (in thousands)

Description	Industry		Spread Above Index(1)		LIBOR Floor			Interest Rate(2)			Maturity Date		Par Amount		Cost		Fair Value(3)
AccentCare, Inc.		Health Care Providers & Services		L+575		1.00	%		6.75	%		9/3/21	$	7,000	$	6,965	$	6,965
Alera Group Intermediate Holdings, Inc.		Insurance		L+550		1.00	%		6.50	%		12/30/22		5,184		5,134		5,132
American Teleconferencing Services, Ltd. (PGI)(4)		Communications Equipment		L+650		1.00	%		7.50	%		12/8/21		14,429		13,126		14,357
Associated Pathologists, LLC		Health Care Providers & Services		L+500		1.00	%		6.04	%		8/1/21		1,604		1,590		1,598
CIBT Holdings, Inc.		Professional Services		L+525		1.00	%		6.40	%		6/28/22		5,214		5,167		5,188
Empower Payments Acquisition, Inc. (RevSpring)		Professional Services		L+550		1.00	%		6.65	%		11/30/23		6,920		6,787		6,782
Falmouth Group Holdings Corp. (AMPAC)(4)		Chemicals		L+675		1.00	%		7.75	%		12/14/21		10,917		10,917		10,917
Island Medical Management Holdings, LLC(4)		Health Care Providers & Services		L+550		1.00	%		6.50	%		9/1/22		6,906		6,837		6,837
Pet Holdings ULC & Pet Supermarket, Inc.		Specialty Retail		L+550		1.00	%		6.50	%		7/5/22		9,259		9,132		9,143
Polycom, Inc.		Communications Equipment		L+525		1.00	%		6.25	%		9/27/23		11,050		10,631		11,050
PPT Management Holdings, LLC		Health Care Providers & Services		L+600		1.00	%		7.15	%		12/16/22		9,975		9,879		9,875
Professional DataSolutions, Inc.		Software		L+550		1.00	%		6.50	%		5/20/22		5,000		4,925		4,925
PSKW, LLC & PDR, LLC		Health Care Providers & Services		L+425		1.00	%		5.40	%		11/25/21		963		963		963
PSKW, LLC & PDR, LLC		Health Care Providers & Services		L+836		1.00	%		9.51	%		11/25/21		8,900		8,754		8,756
U.S. Anesthesia Partners Inc.		Health Care Providers & Services		L+500		1.00	%		6.00	%		12/31/19		4,975		4,930		4,950
VetCor Professional Practices LLC		Health Care Facilities		L+600		1.00	%		7.15	%		4/20/21		3,910		3,839		3,832
															$	109,576	$	111,270

(1) Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or PRIME rate. These instruments are typically subject to a LIBOR or PRIME rate floor.

(2) Floating rate debt investments typically bear interest at a rate determined by reference to either the London Interbank Offered Rate (“LIBOR” or “L”) index rate or the prime index rate (PRIME or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of March 31, 2017.

(3) Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.

(4) The Company also holds this security on its Consolidated Statements of Assets and Liabilities.

47

SSLP II Portfolio as of December 31, 2016 (audited) (in thousands)

Description	Industry		Spread Above Index(1)		LIBOR Floor			Interest Rate(2)			Maturity Date		Par Amount		Cost		Fair Value(3)
Alera Group Intermediate Holdings, Inc.		Insurance		L+550		1.00	%		6.50	%		12/30/22	$	5,184	$	5,132	$	5,132
American Teleconferencing Services, Ltd. (PGI)(4)		Communications Equipment		L+650		1.00	%		7.50	%		12/8/21		14,619		13,244		14,217
Associated Pathologists, LLC		Health Care Providers & Services		L+500		1.00	%		6.00	%		8/1/21		1,646		1,631		1,638
CIBT Holdings, Inc.		Professional Services		L+525		1.00	%		6.25	%		6/28/22		5,241		5,191		5,188
Empower Payments Acquisition, Inc. (RevSpring)		Professional Services		L+550		1.00	%		6.50	%		11/30/23		6,938		6,800		6,799
Falmouth Group Holdings Corp. (AMPAC)(4)		Chemicals		L+675		1.00	%		7.75	%		12/14/21		10,945		10,945		10,945
Pet Holdings ULC & Pet Supermarket, Inc.		Specialty Retail		L+550		1.00	%		6.50	%		7/5/22		9,075		8,947		8,962
Polycom, Inc.		Communications Equipment		L+650		1.00	%		7.50	%		9/27/23		11,605		11,152		11,547
PPT Management Holdings, LLC		Health Care Providers & Services		L+600		1.00	%		7.00	%		12/16/22		10,000		9,901		9,900
PSKW, LLC & PDR, LLC		Health Care Providers & Services		L+425		1.00	%		5.25	%		11/25/21		990		990		990
PSKW, LLC & PDR, LLC		Health Care Providers & Services		L+839		1.00	%		9.39	%		11/25/21		8,900		8,748		8,744
U.S. Anesthesia Partners Inc.		Health Care Providers & Services		L+500		1.00	%		6.00	%		12/31/19		4,988		4,938		4,938
VetCor Professional Practices LLC		Health Care Facilities		L+625		1.00	%		7.25	%		4/20/21		2,840		2,787		2,797
															$	90,406	$	91,797

(1) Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or PRIME rate. These instruments are typically subject to a LIBOR or PRIME rate floor.

(2) Floating rate debt investments typically bear interest at a rate determined by reference to either the London Interbank Offered Rate (“LIBOR” or “L”) index rate or the prime index rate (PRIME or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2016.

(3) Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.

(4) The Company also holds this security on its Consolidated Statements of Assets and Liabilities.

Below is certain summarized financial information for SSLP II as of March 31, 2017 and December 31, 2016 and for the three months ended March 31, 2017:

	March 31, 2017		December 31, 2016 (audited)
Selected Balance Sheet Information for SSLP II (in thousands):
Investments at fair value (cost $109,576 and $90,406, respectively)	$	111,270	$	91,797
Cash and other assets		3,099		1,670
Total assets	$	114,369	$	93,467
Debt outstanding	$	45,250	$	32,950
Payable for investments purchased		6,837		—
Distributions payable		1,463		1,460
Interest payable and other credit facility related expenses		405		147
Accrued expenses and other payables		223		183
Total liabilities	$	54,178	$	34,740
Members’ equity	$	60,191	$	58,727
Total liabilities and members’ equity	$	114,369	$	93,467

48

	Three months ended March 31, 2017
Selected Income Statement Information for SSLP II (in thousands):
Interest income	$	2,091
Service fees*	$	24
Interest and other credit facility expenses		418
Other general and administrative expenses		25
Total expenses	$	467
Net investment income	$	1,624
Net change in unrealized gain on investments		303
Net income	$	1,927

* Service fees are included within the Company’s Consolidated Statements of Operations as other income.

Stock Repurchase Programs

On July 31, 2013, the Board authorized a program for the purpose of repurchasing up to $100 million of the Company’s common stock. Under the repurchase program, the Company could have, but was not obligated to, repurchase its outstanding common stock in the open market from time to time provided that the Company complied with the prohibitions under its Insider Trading Policies and Procedures and the guidelines specified in Rules 10b-18 and 10b-5 under the Securities Exchange Act of 1934, as amended, including certain price, market volume and timing constraints. On December 5, 2013, the Board extended the repurchase program to be in place until the earlier of July 31, 2014 or until $100 million of the Company’s outstanding shares of common stock had been repurchased. On July 31, 2014, the Company’s stock repurchase program expired. During the fiscal year ended December 31, 2014, the Company repurchased 1,779,033 shares at an average price of approximately $21.97 per share, inclusive of commissions. The total dollar amount of shares repurchased in that period was $39.1 million. During the year ended December 31, 2013, the Company repurchased 796,418 shares at an average price of approximately $21.98 per share, inclusive of commissions, for a total dollar amount of $17.5 million.

On October 7, 2015, the Board authorized a new share repurchase program to purchase common stock in the open market in an amount up to $30 million. Under the repurchase program, the Company may, but is not obligated to, repurchase its outstanding common stock in the open market from time to time provided that the Company complies with the prohibitions under its Insider Trading Policies and Procedures and the guidelines specified in Rules 10b-18 and 10b-5 under the Securities Exchange Act of 1934, as amended, including certain price, market volume and timing constraints. During the year ended December 31, 2016, the Company repurchased 216,237 shares at an average price of $15.76 per share, inclusive of commissions. The total dollar amount of shares repurchased during the year ended December 31, 2016 was $3.4 million. On October 7, 2016, the Company’s stock repurchase program expired.

Critical Accounting Policies

The preparation of consolidated financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and revenues and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following items as critical accounting policies. Within the context of these critical accounting policies and disclosed subsequent events herein, we are not currently aware of any other reasonably likely events or circumstances that would result in materially different amounts being reported.

49

Valuation of Portfolio Investments

We conduct the valuation of our assets, pursuant to which our net asset value is determined, at all times consistent with GAAP, and the 1940 Act. Our valuation procedures are set forth in more detail below:

Under procedures established by our board of directors (the “Board”), we value investments, including certain senior secured debt, subordinated debt and other debt securities with maturities greater than 60 days, for which market quotations are readily available, at such market quotations (unless they are deemed not to represent fair value). We attempt to obtain market quotations from at least two brokers or dealers (if available, otherwise from a principal market maker or a primary market dealer or other independent pricing service). We utilize mid-market pricing as a practical expedient for fair value unless a different point within the range is more representative. If and when market quotations are deemed not to represent fair value, we typically utilize independent third-party valuation firms to assist us in determining fair value. Accordingly, such investments go through our multi-step valuation process as described below. In each case, independent valuation firms consider observable market inputs together with significant unobservable inputs in arriving at their valuation recommendations. Debt investments with maturities of 60 days or less shall each be valued at cost plus accreted discount, or minus amortized premium, which is expected to approximate fair value, unless such valuation, in the judgment of the Investment Adviser, does not represent fair value, in which case such investments shall be valued at fair value as determined in good faith by or under the direction of our Board. Investments that are not publicly traded or whose market quotations are not readily available are valued at fair value as determined in good faith by or under the direction of our Board. Such determination of fair values involves subjective judgments and estimates.

With respect to investments for which market quotations are not readily available or when such market quotations are deemed not to represent fair value, our Board has approved a multi-step valuation process each quarter, as described below:

(1) our quarterly valuation process begins with each portfolio company or investment being initially valued by the investment professionals of the Investment Adviser responsible for the portfolio investment;

(2) preliminary valuation conclusions are then documented and discussed with senior management of the Investment Adviser;

(3) independent valuation firms engaged by our Board conduct independent appraisals and review the Investment Adviser’s preliminary valuations and make their own independent assessment for all material assets;

(4) the audit committee of the Board reviews the preliminary valuation of the Investment Adviser and that of the independent valuation firm and responds to the valuation recommendation of the independent valuation firm to reflect any comments; and

(5) the Board discusses valuations and determines the fair value of each investment in our portfolio in good faith based on the input of the Investment Adviser, the respective independent valuation firm and the audit committee.

Investments in all asset classes are valued utilizing a market approach, an income approach, or both approaches, as appropriate. However, in accordance with ASC 820-10, certain investments that qualify as investment companies in accordance with ASC 946, may be valued using net asset value as a practical expedient for fair value. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities (including a business). The income approach uses valuation approaches to convert future amounts (for example, cash flows or earnings) to a single present amount (discounted). The measurement is based on the value indicated by current market expectations about those future amounts. In following these approaches, the types of factors that we may take into account in fair value pricing our investments include, as relevant: available current market data, including relevant and applicable market

50

trading and transaction comparables, applicable market yields and multiples, security covenants, call protection provisions, the nature and realizable value of any collateral, the portfolio company’s ability to make payments, its earnings and discounted cash flows, the markets in which the portfolio company does business, comparisons of financial ratios of peer companies that are public, M&A comparables, our principal market (as the reporting entity) and enterprise values, among other factors. When available, broker quotations and/or quotations provided by pricing services are considered as an input in the valuation process. For the three months ended March 31, 2017, there has been no change to the Company’s valuation approaches or techniques and the nature of the related inputs considered in the valuation process.

Accounting Standards Codification (“ASC”) Topic 820 classifies the inputs used to measure these fair values into the following hierarchy:

Level 1: Quoted prices in active markets for identical assets or liabilities, accessible by the Company at the measurement date.

Level 2: Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or other observable inputs other than quoted prices.

Level 3: Unobservable inputs for the asset or liability.

In all cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each investment. The exercise of judgment is based in part on our knowledge of the asset class and our prior experience.

Determination of fair value involves subjective judgments and estimates. Accordingly, the notes to our consolidated financial statements express the uncertainty with respect to the possible effect of such valuations, and any change in such valuations, on our consolidated financial statements.

Valuation of Credit Facility, Senior Secured Notes and 2022 Unsecured Notes

The Company has made an irrevocable election to apply the fair value option of accounting to its Credit Facility, Senior Secured Notes and 2022 Unsecured Notes, in accordance with ASC 825-10. We believe accounting for the Credit Facility, Senior Secured Notes and 2022 Unsecured Notes at fair value better aligns the measurement methodologies of assets and liabilities, which may mitigate certain earnings volatility.

Revenue Recognition

The Company records dividend income and interest, adjusted for amortization of premium and accretion of discount, on an accrual basis. Investments that are expected to pay regularly scheduled interest and/or dividends in cash are generally placed on non-accrual status when principal or interest/dividend cash payments are past due 30 days or more and/or when it is no longer probable that principal or interest/dividend cash payments will be collected. Such non-accrual investments are restored to accrual status if past due principal and interest or dividends are paid in cash, and in management’s judgment, are likely to continue timely payment of their remaining interest or dividend obligations. Interest or dividend cash payments received on investments may be recognized as income or applied to principal depending upon management’s judgment. Some of our investments may have contractual PIK interest or dividends. PIK interest and dividends computed at the contractual rate are accrued into income and reflected as receivable up to the capitalization date. PIK investments offer issuers the option at each payment date of making payments in cash or in additional securities. When additional securities are received, they typically have the same terms, including maturity dates and interest rates as the original securities issued. On these payment dates, the Company capitalizes the accrued interest or dividends receivable

51

(reflecting such amounts as the basis in the additional securities received). PIK generally becomes due at the maturity of the investment or upon the investment being called by the issuer. At the point the Company believes PIK is not expected to be realized, the PIK investment will be placed on non-accrual status. When a PIK investment is placed on non-accrual status, the accrued, uncapitalized interest or dividends is reversed from the related receivable through interest or dividend income, respectively. The Company does not reverse previously capitalized PIK interest or dividends. Upon capitalization, PIK is subject to the fair value estimates associated with their related investments. PIK investments on non-accrual status are restored to accrual status if the Company again believes that PIK is expected to be realized. Loan origination fees, original issue discount, and market discounts are capitalized and amortized into income using the interest method or straight-line, as applicable. Upon the prepayment of a loan, any unamortized loan origination fees are recorded as interest income. We record prepayment premiums on loans and other investments as interest income when we receive such amounts. Capital structuring fees are recorded as other income when earned.

The typically higher yields and interest rates on PIK securities, to the extent we invested, reflects the payment deferral and increased credit risk associated with such instruments and that such investments may represent a significantly higher credit risk than coupon loans. PIK securities may have unreliable valuations because their continuing accruals require continuing judgments about the collectability of the deferred payments and the value of any associated collateral. PIK interest has the effect of generating investment income and increasing the incentive fees payable at a compounding rate. In addition, the deferral of PIK interest also increases the loan-to-value ratio at a compounding rate. PIK securities create the risk that incentive fees will be paid to the Investment Adviser based on non-cash accruals that ultimately may not be realized, but the Investment Adviser will be under no obligation to reimburse the Company for these fees. For the three months ended March 31, 2017 and 2016, capitalized PIK income totaled $0.04 million and $0.0 million, respectively.

Net Realized Gain or Loss and Net Change in Unrealized Gain or Loss

We generally measure realized gain or loss by the difference between the net proceeds from the repayment or sale and the amortized cost basis of the investment, without regard to unrealized appreciation or depreciation previously recognized, but considering unamortized origination or commitment fees and prepayment penalties. The net change in unrealized gain or loss reflects the change in portfolio investment values during the reporting period, including the reversal of previously recorded unrealized gain or loss, when gains or losses are realized. Gains or losses on investments are calculated by using the specific identification method.

Income Taxes

Solar Capital, a U.S. corporation, has elected to be treated as a RIC under Subchapter M of the Code. In order to qualify for taxation as a RIC, the Company is required, among other things, to timely distribute to its stockholders at least 90% of investment company taxable income, as defined by the Code, for each year. Depending on the level of taxable income earned in a given tax year, we may choose to carry forward taxable income in excess of current year distributions into the next tax year and pay a 4% excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income will be in excess of estimated current year distributions, the Company accrues an estimated excise tax, if any, on estimated excess taxable income.

Recent Accounting Pronouncements

In October 2016, the U.S. Securities and Exchange Commission adopted new rules and amended rules (together, “final rules”) interned to modernize the reporting and disclosure of information by registered investment companies. In part, the final rules amend Regulation S-X and require standardized, enhanced disclosure about derivatives in investment company financial statements, as well as other amendments. The compliance date for the amendments to Regulation S-X is August 1, 2017. The Company is currently evaluating

52

the impact that the adoption of the amendments to Regulation S-X will have on its consolidated financial statements and disclosures.

In November 2016, FASB issued ASU 2016-18, Statement of Cash Flows, which will amend FASB ASC 230. The amendments in this Update require that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. The amendments in this Update apply to all entities that have restricted cash or restricted cash equivalents and are required to present a statement of cash flows under Topic 230. For public business entities, the amendments are effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted, including adoption in an interim period. The Company is evaluating the impact of ASU 2016-18 on its consolidated financial statements and disclosures.

In December 2016, the FASB issued ASU 2016-19, Technical Corrections and Improvements. As part of this guidance, ASU 2016-19 amends FASB ASC 820 to clarify the difference between a valuation approach and a valuation technique. The amendment also requires an entity to disclose when there has been a change in either or both a valuation approach and/or a valuation technique. ASU 2016-19 is effective on a prospective basis for financial statements issued for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016 on a prospective basis. The Company has evaluated the impact of ASU 2016-19 on its consolidated financial statements and disclosures and determined that the adoption of ASU 2016-19 has not had a material impact on its consolidated financial statements.

RESULTS OF OPERATIONS

Results comparisons are for the three months ended March 31, 2017 and 2016:

Investment Income

For the three months ended March 31, 2017 and 2016, gross investment income totaled $34.4 million and $34.0 million, respectively. The increase in gross investment income for the year over year three month periods was primarily due to growth of the dividends from our investments in SSLP and SSLP II.

Expenses

Net expenses totaled $18.1 million and $17.1 million, respectively, for the three months ended March 31, 2017 and 2016, of which $10.8 million and $10.8 million, respectively, were base management fees and performance-based incentive fees and $5.7 million and $5.0 million, respectively, were interest and other credit facility expenses. Administrative services and other general and administrative expenses totaled $1.6 million and $2.1 million, respectively, for the three months ended March 31, 2017 and 2016. Expenses generally consist of management and performance-based incentive fees, administrative services fees, insurance expenses, legal fees, directors’ fees, transfer agency fees, printing and proxy expenses, audit and tax services expenses, and other general and administrative expenses. Interest and other credit facility expenses generally consist of interest, unused fees, agency fees and loan origination fees, if any, among others. The increase in expenses for the three months ended March 31, 2017 versus the three months ended March 31, 2016 was primarily due to higher net performance-based incentive fees, as there was no waiver in the March 2017 quarter, and higher interest expense as we expensed $0.5 million in conjunction with the February issue of 2022 Unsecured Notes.

53

Net Investment Income

The Company’s net investment income totaled $16.3 million and $16.9 million, or $0.39 and $0.40, per average share, respectively, for the three months ended March 31, 2017 and 2016.

Net Realized Gain (Loss)

The Company had investment sales and prepayments totaling approximately $85 million and $31 million, respectively, for the three months ended March 31, 2017 and 2016. Net realized gains over the same periods were $0.6 million and $0.0 million, respectively. Net realized gains for the three months ended March 31, 2017 were related to the sale of select assets. Net realized gains for the three months ended March 31, 2016 were de minimis.

Net Change in Unrealized Gain (Loss)

For the three months ended March 31, 2017 and 2016, net change in unrealized gain on the Company’s assets and liabilities totaled $0.3 million and $11.3 million, respectively. Net unrealized gain for the three months ended March 31, 2017 is primarily due to appreciation in the value of our investments in Crystal Financial LLC, Breathe Technologies, Inc. and Tierpoint, LLC, among others. Partially offsetting the net change in unrealized gain was depreciation on our investments in Aegis Toxicology Sciences Corporation, Rug Doctor and Direct Buy Inc. among others. Net unrealized gain for the three months ended March 31, 2016 is primarily due to appreciation in the value of our investments in WireCo Worldgroup Inc., Rug Doctor, Crystal Financial, LLC, Global Tel*Link Corporation and Asurion, LLC, among others. Partially offsetting the net change in unrealized gain was depreciation on our investments in Bishop Lifting Products, Inc., Aegis Toxicology Sciences Corporation and Direct Buy, Inc., among others.

Net Increase in Net Assets From Operations

For the three months ended March 31, 2017 and 2016, the Company had a net increase in net assets resulting from operations of $17.2 million and $28.2 million, respectively. For the same periods, earnings per average share were $0.41 and $0.67, respectively.

LIQUIDITY AND CAPITAL RESOURCES

The Company’s liquidity and capital resources are generated and generally available through its Credit Facility maturing in September 2021, through cash flows from operations, investment sales, prepayments of senior and subordinated loans, income earned on investments and cash equivalents, and periodic follow-on equity and/or debt offerings. As of March 31, 2017, we had a total of $395.0 million of unused borrowing capacity under the Credit Facility, subject to borrowing base limits.

We may from time to time issue equity and/or debt securities in either public or private offerings. The issuance of such securities will depend on future market conditions, funding needs and other factors and there can be no assurance that any such issuance will occur or be successful. The primary uses of existing funds and any funds raised in the future is expected to be for investments in portfolio companies, repayment of indebtedness, cash distributions to our shareholders, or for other general corporate purposes.

On February 15, 2017, the Company closed a private offering of $100 million of the 2022 Unsecured Notes with a fixed interest rate of 4.60% and a maturity date of May 8, 2022. Interest on the 2022 Unsecured Notes is due semi-annually on May 8 and November 8. The 2022 Unsecured Notes were issued in a private placement only to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

54

On November 8, 2016, the Company closed a private offering of $50 million of the 2022 Unsecured Notes with a fixed interest rate of 4.40% and a maturity date of May 8, 2022. Interest on the 2022 Unsecured Notes is due semi-annually on May 8 and November 8. The 2022 Unsecured Notes were issued in a private placement only to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

On January 11, 2013, the Company closed its most recent follow-on public equity offering of 6.3 million shares of common stock raising approximately $146.9 million in net proceeds. The primary uses of the funds raised were for investments in portfolio companies, reductions in revolving debt outstanding and for other general corporate purposes.

On November 16, 2012, we issued $100 million in aggregate principal amount of the 2042 Unsecured Notes for net proceeds of $96.9 million. Interest on the 2042 Unsecured Notes is paid quarterly on February 15, May 15, August 15 and November 15, at a rate of 6.75% per year, commencing on February 15, 2013. The 2042 Unsecured Notes mature on November 15, 2042. The Company may redeem the 2042 Unsecured Notes in whole or in part at any time or from time to time on or after November 15, 2017.

On May 10, 2012, the Company closed a private offering of $75 million of Senior Secured Notes with a fixed interest rate of 5.875% and a maturity date of May 10, 2017. Interest on the Senior Secured Notes is due semi-annually on May 10 and November 10. The Senior Secured Notes were issued in a private placement only to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

The primary uses of existing funds and any funds raised in the future is expected to be for repayment of indebtedness, investments in portfolio companies, cash distributions to our shareholders or for other general corporate purposes.

Cash Equivalents

We deem certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities as cash equivalents. The Company makes purchases that are consistent with its purpose of making investments in securities described in paragraphs 1 through 3 of Section 55(a) of the 1940 Act. From time to time, including at or near the end of each fiscal quarter, we consider using various temporary investment strategies for our business. One strategy includes taking proactive steps by utilizing cash equivalents as temporary assets with the objective of enhancing our investment flexibility pursuant to Section 55 of the 1940 Act. More specifically, from time-to-time we may purchase U.S. Treasury bills or other high-quality, short-term debt securities at or near the end of the quarter and typically close out the position on a net cash basis subsequent to quarter end. We may also utilize repurchase agreements or other balance sheet transactions, including drawing down on our credit facilities, as deemed appropriate. The amount of these transactions or such drawn cash for this purpose is excluded from total assets for purposes of computing the asset base upon which the management fee is determined. We held approximately $400 million in cash equivalents as of March 31, 2017.

Debt

Unsecured Notes

On February 15, 2017, the Company closed a private offering of $100 million of the 2022 Unsecured Notes with a fixed interest rate of 4.60% and a maturity date of May 8, 2022. Interest on the 2022 Unsecured Notes is due semi-annually on May 8 and November 8. The 2022 Unsecured Notes were issued in a private placement only to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

On November 8, 2016, the Company closed a private offering of $50 million of the 2022 Unsecured Notes with a fixed interest rate of 4.40% and a maturity date of May 8, 2022. Interest on the 2022 Unsecured Notes is due semi-annually on May 8 and November 8. The 2022 Unsecured Notes were issued in a private placement only to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

55

On November 16, 2012, the Company and U.S. Bank National Association entered into an Indenture and a First Supplemental Indenture relating to the Company’s issuance, offer and sale of $100 million aggregate principal amount of its 2042 Unsecured Notes. The 2042 Unsecured Notes will mature on November 15, 2042 and may be redeemed in whole or in part at the Company’s option at any time or from time to time on or after November 15, 2017 at a redemption price of $25 per security plus accrued and unpaid interest. The 2042 Unsecured Notes bear interest at a rate of 6.75% per year payable quarterly on February 15, May 15, August 15 and November 15 of each year. The 2042 Unsecured Notes are direct senior unsecured obligations of the Company.

Revolving & Term Loan Facility

On September 30, 2016, the Company entered into a second Credit Facility amendment. Post amendment, the Credit Facility was composed of $505 million of revolving credit and $50 million of term loans. Borrowings generally bear interest at a rate per annum equal to the base rate plus a range of 2.00-2.25% or the alternate base rate plus 1.00%-1.25%. The Credit Facility has no LIBOR floor requirement. The Credit Facility matures in September 2021 and includes ratable amortization in the final year. The Credit Facility may be increased up to $800 million with additional new lenders or an increase in commitments from current lenders. The Credit Facility contains certain customary affirmative and negative covenants and events of default. In addition, the Credit Facility contains certain financial covenants that among other things, requires the Company to maintain a minimum shareholder’s equity and a minimum asset coverage ratio. The Company also pays issuers of funded term loans quarterly in arrears a commitment fee at the rate of 0.25% per annum on the average daily outstanding balance. On February 23, 2017, the Company prepaid its non-extending lenders and terminated their commitments, reducing total outstanding revolving credit commitments by $110 million to $395 million. At March 31, 2017, outstanding USD equivalent borrowings under the Credit Facility totaled $50 million, comprised solely of outstanding term loans.

Senior Secured Notes

On May 10, 2012, the Company closed a private offering of $75 million of Senior Secured Notes with a fixed interest rate of 5.875% and a maturity date of May 10, 2017. Interest on the Senior Secured Notes is due semi-annually on May 10 and November 10. The Senior Secured Notes were issued in a private placement only to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

Certain covenants on our issued debt may restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain our status as a RIC under Subchapter M of the Code. At March 31, 2017, the Company was in compliance with all financial and operational covenants required by the Credit Facilities.

Contractual Obligations

A summary of our significant contractual payment obligations is as follows as of March 31, 2017:

Payments Due by Period (in millions)

	Total		Less than 1 Year		1-3 Years		3-5 Years		More Than 5 Years
Revolving credit facility(1)	$	—	$	—	$	—	$	—	$	—
Unsecured senior notes		150.0		—		—		—		150.0
Senior secured notes		75.0		75.0		—		—		—
Term Loans		50.0		—		—		50.0		—

(1) As of March 31, 2017, we had a total of $395.0 million of unused borrowing capacity under our revolving credit facilities, subject to borrowing base limits.

56

Information about our senior securities is shown in the following table (in thousands) as of each year ended December 31 since the Company commenced operations, unless otherwise noted. The “—” indicates information which the SEC expressly does not require to be disclosed for certain types of senior securities.

Class and Year	Total Amount Outstanding(1)		Asset Coverage Per Unit(2)		Involuntary Liquidating Preference Per Unit(3)		Average Market Value Per Unit(4)
Revolving Credit Facilities
Fiscal 2017 (through March 31, 2017)	$	—	$	—		—		N/A
Fiscal 2016		115,200		990		—		N/A
Fiscal 2015		207,900		1,459		—		N/A
Fiscal 2014		—		—		—		N/A
Fiscal 2013		—		—		—		N/A
Fiscal 2012		264,452		1,510		—		N/A
Fiscal 2011		201,355		3,757		—		N/A
Fiscal 2010		400,000		2,668		—		N/A
Fiscal 2009		88,114		8,920		—		N/A
2022 Unsecured Notes
Fiscal 2017 (through March 31, 2017)	$	150,000	$	1,380		—		N/A
Fiscal 2016		50,000		430		—		N/A
2042 Unsecured Notes
Fiscal 2017 (through March 31, 2017)	$	100,000	$	920		—	$	1,010
Fiscal 2016		100,000		859		—		1,002
Fiscal 2015		100,000		702		—		982
Fiscal 2014		100,000		2,294		—		943
Fiscal 2013		100,000		2,411		—		934
Fiscal 2012		100,000		571		—		923
Senior Secured Notes
Fiscal 2017 (through March 31, 2017)	$	75,000	$	690		—		N/A
Fiscal 2016		75,000		645		—		N/A
Fiscal 2015		75,000		527		—		N/A
Fiscal 2014		75,000		1,721		—		N/A
Fiscal 2013		75,000		1,808		—		N/A
Fiscal 2012		75,000		428		—		N/A
Term Loans
Fiscal 2017 (through March 31, 2017)	$	50,000	$	460		—		N/A
Fiscal 2016		50,000		430		—		N/A
Fiscal 2015		50,000		351		—		N/A
Fiscal 2014		50,000		1,147		—		N/A
Fiscal 2013		50,000		1,206		—		N/A
Fiscal 2012		50,000		285		—		N/A
Fiscal 2011		35,000		653		—		N/A
Fiscal 2010		35,000		233		—		N/A
Total Senior Securities
Fiscal 2017 (through March 31, 2017)	$	375,000	$	3,450		—		N/A
Fiscal 2016		390,200		3,354		—		N/A
Fiscal 2015		432,900		3,039		—		N/A
Fiscal 2014		225,000		5,162		—		N/A
Fiscal 2013		225,000		5,425		—		N/A
Fiscal 2012		489,452		2,794		—		N/A
Fiscal 2011		236,355		4,410		—		N/A
Fiscal 2010		435,000		2,901		—		N/A
Fiscal 2009		88,114		8,920		—		N/A

(1) Total amount of each class of senior securities outstanding at the end of the period presented.

(2) The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to

57

determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of March 31, 2017, asset coverage was 345.0%.

(3) The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it.

(4) Not applicable except for the 2042 Unsecured Notes which are publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2017, 2016, 2015, 2014, 2013 and 2012 periods was $100,983, $100,175, $98,196, $94,301, $93,392, and $92,302, respectively.

We have also entered into two contracts under which we have future commitments: the Advisory Agreement, pursuant to which Solar Capital Partners, LLC has agreed to serve as our investment adviser, and the Administration Agreement, pursuant to which the Administrator has agreed to furnish us with the facilities and administrative services necessary to conduct our day-to-day operations and provide on our behalf managerial assistance to those portfolio companies to which we are required to provide such assistance. Payments under the Advisory Agreement are equal to (1) a percentage of the value of our average gross assets and (2) a two-part incentive fee. Payments under the Administration Agreement are equal to an amount based upon our allocable portion of the Administrator’s overhead in performing its obligations under the Administration Agreement, including rent, technology systems, insurance and our allocable portion of the costs of our chief financial officer and chief compliance officer and their respective staffs. Either party may terminate each of the Advisory Agreement and administration agreement without penalty upon 60 days’ written notice to the other. See note 3 to our Consolidated Financial Statements.

On October 15, 2015, SSLP entered into an amended and restated servicing agreement with the Company. SSLP engaged and retained the Company to provide certain administrative services relating to the facilities, supplies and necessary ongoing overhead support services for the operation of SSLP’s ongoing business affairs in exchange for a fee. Either party may terminate this agreement upon 30 days’ written notice to the other.

On August 5, 2016, SSLP II entered into a servicing agreement with the Company. SSLP II engaged and retained the Company to provide certain administrative services relating to the facilities, supplies and necessary ongoing overhead support services for the operation of SSLP II’s ongoing business affairs in exchange for a fee. Either party may terminate this agreement upon 30 days’ written notice to the other.

Off-Balance Sheet Arrangements

The Company had unfunded debt and equity commitments to various delayed draw loans as well as to Crystal Financial LLC. The total amount of these unfunded commitments as of March 31, 2017 and December 31, 2016 is $51.7 million and $64.0 million, respectively, comprised of the following:

	March 31, 2017		December 31, 2016
Crystal Financial LLC	$	44.3	$	44.3
aTyr Pharma, Inc		5.0		5.0
CardioFocus, Inc		2.0		—
Island Medical Management Holdings, LLC		0.4		—
Vapotherm, Inc		—		10.0
SentreHeart, Inc		—		2.5
Conventus Orthopaedics, Inc		—		2.2
Total Commitments*	$	51.7	$	64.0

* The Company controls the funding of the Crystal Financial LLC commitment and may cancel it at its discretion.

58

As of March 31, 2017 and December 31, 2016, the Company had sufficient cash available and/or liquid securities available to fund its commitments as well as the commitments to Senior Secured Unitranche Loan Program LLC (“SSLP”), Senior Secured Unitranche Loan Program II LLC (“SSLP II”) and Solar Life Science Program LLC (“LSJV”), all disclosed in the notes to the Consolidated Financial Statements.

In the normal course of its business, we invest or trade in various financial instruments and may enter into various investment activities with off-balance sheet risk, which may include forward foreign currency contracts. Generally, these financial instruments represent future commitments to purchase or sell other financial instruments at specific terms at future dates. These financial instruments contain varying degrees of off-balance sheet risk whereby changes in the market value or our satisfaction of the obligations may exceed the amount recognized in our Consolidated Statements of Assets and Liabilities.

Distributions

The following table reflects the cash distributions per share on our common stock for the two most recent fiscal years and the current fiscal year to date:

Date Declared	Record Date		Payment Date		Amount
Fiscal 2017
May 2, 2017		June 22, 2017		July 5, 2017	$	0.40
February 22, 2017		March 23, 2017		April 4, 2017		0.40
Total 2016					$	0.80
Fiscal 2016
November 2, 2016		December 15, 2016		January 4, 2017	$	0.40
August 2, 2016		September 22, 2016		October 4, 2016		0.40
May 3, 2016		June 23, 2016		July 1, 2016		0.40
February 24, 2016		March 24, 2016		April 1, 2016		0.40
Total 2016					$	1.60
Fiscal 2015
November 3, 2015		December 17, 2015		January 6, 2016	$	0.40
August 4, 2015		September 24, 2015		October 2, 2015		0.40
May 5, 2015		June 25, 2015		July 1, 2015		0.40
February 25, 2015		March 19, 2015		April 2, 2015		0.40
Total 2015					$	1.60

Tax characteristics of all distributions will be reported to shareholders on Form 1099 after the end of the calendar year. Future quarterly distributions, if any, will be determined by our Board. We expect that our distributions to stockholders will generally be from accumulated net investment income, from net realized capital gains or non-taxable return of capital, if any, as applicable.

We have elected to be taxed as a RIC under Subchapter M of the Code. To maintain our RIC status, we must distribute at least 90% of our ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses, if any, out of the assets legally available for distribution. In addition, although we currently intend to distribute realized net capital gains (i.e., net long-term capital gains in excess of short-term capital losses), if any, at least annually, out of the assets legally available for such distributions, we may in the future decide to retain such capital gains for investment.

We maintain an “opt out” dividend reinvestment plan for our common stockholders. As a result, if we declare a distribution, then stockholders’ cash distributions will be automatically reinvested in additional shares

59

of our common stock, unless they specifically “opt out” of the dividend reinvestment plan so as to receive cash distributions.

We may not be able to achieve operating results that will allow us to make distributions at a specific level or to increase the amount of these distributions from time to time. In addition, due to the asset coverage test applicable to us as a business development company, we may in the future be limited in our ability to make distributions. Also, our revolving credit facility may limit our ability to declare distributions if we default under certain provisions. If we do not distribute a certain percentage of our income annually, we will suffer adverse tax consequences, including possible loss of the tax benefits available to us as a regulated investment company. In addition, in accordance with GAAP and tax regulations, we include in income certain amounts that we have not yet received in cash, such as contractual payment-in-kind interest, which represents contractual interest added to the loan balance that becomes due at the end of the loan term, or the accrual of original issue or market discount. Since we may recognize income before or without receiving cash representing such income, we may have difficulty meeting the requirement to distribute at least 90% of our investment company taxable income to obtain tax benefits as a regulated investment company.

With respect to the distributions to stockholders, income from origination, structuring, closing and certain other upfront fees associated with investments in portfolio companies are treated as taxable income and accordingly, distributed to stockholders.

Related Parties

We have entered into a number of business relationships with affiliated or related parties, including the following:

• We have entered into the Advisory Agreement with Solar Capital Partners. Mr. Gross, our Chairman and Chief Executive Officer and Mr. Spohler, our Chief Operating Officer and board member, are managing members and senior investment professionals of, and have financial and controlling interests in, the Investment Adviser. In addition, Mr. Peteka, our Chief Financial Officer, Treasurer and Corporate Secretary serves as the Chief Financial Officer for Solar Capital Partners.

• The Administrator provides us with the office facilities and administrative services necessary to conduct day-to-day operations pursuant to our Administration Agreement. We reimburse the Administrator for the allocable portion of overhead and other expenses incurred by it in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing compliance functions, and the compensation of our chief compliance officer, our chief financial officer and any administrative support staff.

• We have entered into a license agreement with the Investment Adviser, pursuant to which the Investment Adviser has granted us a non-exclusive, royalty-free license to use the name “Solar Capital.”

The Investment Adviser may also manage other funds in the future that may have investment mandates that are similar, in whole and in part, with ours. For example, the Investment Adviser presently serves as investment adviser to Solar Senior Capital Ltd., a publicly traded BDC, which focuses on investing in senior secured loans, including first lien and second lien debt instruments. In addition, Michael S. Gross, our Chairman and Chief Executive Officer, Bruce Spohler, our Chief Operating Officer, and Richard L. Peteka, our Chief Financial Officer, serve in similar capacities for Solar Senior Capital Ltd. The Investment Adviser and certain investment advisory affiliates may determine that an investment is appropriate for us and for one or more of those other funds. In such event, depending on the availability of such investment and other appropriate factors, the Investment Adviser or its affiliates may determine that we should invest side-by-side with one or more other funds. Any such investments will be made only to the extent permitted by applicable law and interpretive positions of the SEC and its staff, and consistent with the Investment Adviser’s allocation procedures.

60

Related party transactions may occur between Solar Capital Ltd. and Crystal Financial LLC, between Solar Capital Ltd. and Senior Secured Unitranche Loan Program LLC, between Solar Capital Ltd. and SSLP 2016-1, LLC, between Solar Capital Ltd. and Solar Life Science Program LLC, between Solar Capital Ltd. and Senior Secured Unitranche Loan Program II LLC and between Solar Capital Ltd. and SSLP II 2016-1, LLC. These transactions may occur in the normal course of business. No administrative fees are paid to Solar Capital Partners by Crystal Financial LLC, Senior Secured Unitranche Loan Program LLC, Solar Life Science Program LLC or Senior Secured Unitranche Loan Program II LLC.

In addition, we have adopted a formal code of ethics that governs the conduct of our officers and directors. Our officers and directors also remain subject to the duties imposed by both the 1940 Act and the Maryland General Corporation Law.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are subject to financial market risks, including changes in interest rates. During the three months ended March 31, 2017, certain of the investments in our portfolio had floating interest rates. These floating rate investments were primarily based on floating LIBOR and typically have durations of one to three months after which they reset to current market interest rates. Additionally, some of these investments have LIBOR floors. The Company also has revolving credit facilities that are generally based on floating LIBOR. Assuming no changes to our balance sheet as of March 31, 2017 and no new defaults by portfolio companies, a hypothetical one-quarter of one percent decrease in LIBOR on our floating rate assets and liabilities would reduce our net investment income by $0.01 per average share over the next twelve months. Assuming no changes to our balance sheet as of March 31, 2017 and no new defaults by portfolio companies, a hypothetical one percent increase in LIBOR on our floating rate assets and liabilities would increase our net investment income by approximately fifteen cents per average share over the next twelve months. However, we may hedge against interest rate fluctuations from time-to-time by using standard hedging instruments such as futures, options, swaps and forward contracts subject to the requirements of the 1940 Act. While hedging activities may insulate us against adverse changes in interest rates, they may also limit our ability to participate in any benefits of certain changes in interest rates with respect to our portfolio of investments. At March 31, 2017, we have no interest rate hedging instruments outstanding.

Increase (Decrease) in LIBOR	(0.25%)	1.00%
Increase (Decrease) in Net Investment Income Per Share Per Year	($0.01)	$0.15

We may also have exposure to foreign currencies (e.g., Canadian Dollars) through various investments. These investments are converted into U.S. dollars at the balance sheet date, exposing us to movements in foreign exchange rates. In order to reduce our exposure to fluctuations in foreign exchange rates, we may borrow from time-to-time in such currencies (e.g., Canadian Dollars) under our multi-currency revolving credit facility or enter into forward currency contracts.

Item 4. Controls and Procedures

(a) Evaluation of Disclosure Controls and Procedures

As of March 31, 2017 (the end of the period covered by this report), we, including our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the 1934 Act). Based on that evaluation, our management, including the Chief Executive Officer and Chief Financial Officer, concluded that our disclosure controls and procedures were effective and provided reasonable assurance that information required to be disclosed in our periodic SEC filings is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely

61

decisions regarding required disclosure. However, in evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of such possible controls and procedures.

(b) Changes in Internal Controls Over Financial Reporting

Management has not identified any change in the Company’s internal control over financial reporting that occurred during the first quarter of 2017 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

62

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

We, Solar Capital Management, LLC and Solar Capital Partners, LLC are not currently subject to any material pending legal proceedings threatened against us. From time to time, we may be a party to certain legal proceedings incidental to the normal course of our business including the enforcement of our rights under contracts with our portfolio companies. While the outcome of these legal proceedings cannot be predicted with certainty, we do not expect that these proceedings will have a material effect upon our business, financial condition or results of operations beyond what has been disclosed within these financial statements.

Item 1A. Risk Factors

In addition to the other information set forth in this report, you should carefully consider the factors discussed in “Risk Factors” in the April 28, 2017 filing of our Registration Statement on Form N-2, which could materially affect our business, financial condition and/or operating results. The risks described in our Registration Statement on Form N-2 are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially and adversely affect our business, financial condition and/or operating results.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

We did not engage in unregistered sales of securities during the quarter ended March 31, 2017.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

63

Item 6. Exhibits

The following exhibits are filed as part of this report or hereby incorporated by reference to exhibits previously filed with the SEC:

Exhibit Number	Description
3.1	Articles of Amendment and Restatement(1)
3.2	Amended and Restated Bylaws(1)
4.1	Form of Common Stock Certificate(2)
4.2	Indenture, dated as of November 16, 2012, between the Registrant and U.S. Bank National Association as trustee(3)
4.3	First Supplemental Indenture, dated November 16, 2012, relating to the 6.75% Senior Notes due 2042, between the Registrant and U.S. Bank National Association as trustee(3)
4.4	In accordance with Item 601(b)(4)(iii)(A) of Regulation S-K, certain instruments respecting long-term debt of the Registrant have been omitted but will be furnished to the SEC upon request
10.1	Dividend Reinvestment Plan(1)
10.2	Form of Senior Secured Credit Agreement by and between the Registrant, Citibank, N.A., as administrative agent, the lenders party thereto, JPMorgan Chase Bank, N.A., as syndication agent, and SunTrust Bank, as documentation agent(9)
10.3	Form of Amendment No. 1 to the Senior Secured Credit Agreement by and between the Registrant, the Lenders and Citibank, N.A., as administrative agent(5)
10.4	Form of Amendment No. 2 to the Senior Secured Credit Agreement by and between the Registrant, the Lenders and Citibank, N.A., as administrative agent(10)
10.5	First Amended and Restated Investment Advisory and Management Agreement by and between the Registrant and Solar Capital Partners, LLC(11)
10.6	Form of Custodian Agreement(7)
10.7	Amended and Restated Administration Agreement by and between Registrant and Solar Capital Management, LLC(6)
10.8	Form of Indemnification Agreement by and between Registrant and each of its directors(1)
10.9	Trademark License Agreement by and between Registrant and Solar Capital Partners, LLC(1)
10.10	Form of Share Purchase Agreement by and between Registrant and Solar Capital Investors II, LLC(2)
10.11	Form of Registration Rights Agreement(4)
10.12	Form of Subscription Agreement(4)
10.13	Form of Amended and Restated Limited Liability Company Agreement, dated as of October 15, 2015, between Solar Capital Ltd., Voya Retirement Insurance and Annuity Company, ReliaStar Life Insurance Company, and Voya Insurance and Annuity Company, by and through Voya Investment Management LLC, as agent and investment manager(8)
10.14	Form of Senior Secured Unitranche Loan Program II LLC Amended and Restated Limited Liability Company Agreement, dated as of August 5, 2016, by and between Solar Capital Ltd. and WFI Loanco, LLC(12)

64

Exhibit Number	Description
10.15	Form of Solar Life Science Program LLC Limited Liability Company Agreement, dated as of February 22, 2017, by and between Solar Capital Ltd., Solar Senior Capital Ltd. and Deerfield Solar Holdings LLC*
11.1	Computation of Per Share Earnings (included in the notes to the financial statements contained in this report)
31.1	Certification of Chief Executive Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended.*
31.2	Certification of Chief Financial Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended.*
32.1	Certification of Chief Executive Officer pursuant to Section 906 of The Sarbanes-Oxley Act of 2002.*
32.2	Certification of Chief Financial Officer pursuant to Section 906 of The Sarbanes-Oxley Act of 2002.*

(1) Previously filed in connection with Solar Capital Ltd.’s registration statement on Form N-2 Pre-Effective Amendment No. 7 (File No. 333-148734) filed on January 7, 2010.

(2) Previously filed in connection with Solar Capital Ltd.’s registration statement on Form N-2 (File No 333-148734) filed on February 9, 2010.

(3) Previously filed in connection with Solar Capital Ltd.’s registration statement on Form N-2 Post-Effective Amendment No. 6 (File No. 333-172968) filed on November 16, 2012.

(4) Previously filed in connection with Solar Capital Ltd.’s report on Form 8-K filed on November 29, 2010.

(5) Previously filed in connection with Solar Capital Ltd.’s report on Form 10-Q filed on July 31, 2013.

(6) Previously filed in connection with Solar Capital Ltd.’s registration statement on Form N-2 Post-Effective Amendment No. 10 (File No. 333-172968) filed on November 12, 2013.

(7) Previously filed in connection with Solar Capital Ltd.’s report on Form 10-K filed on February 25, 2014.

(8) Previously filed in connection with Solar Capital Ltd.’s report on Form 10-Q filed on November 3, 2015.

(9) Previously filed in connection with Solar Capital Ltd.’s report on Form 8-K filed on July 6, 2012.

(10) Previously filed in connection with Solar Capital Ltd.’s report on Form 10-Q filed on November 2, 2016.

(11) Previously filed in connection with Solar Capital Ltd.’s report on Form 10-Q filed on August 2, 2016.

(12) Previously filed in connection with Solar Capital Ltd.’s report on Form 8-K filed on August 11, 2016.

* Filed herewith.

65

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on May 2, 2017.

SOLAR CAPITAL LTD.
By:	/S/    MICHAEL S. GROSS
	Michael S. Gross Chief Executive Officer (Principal Executive Officer)
By:	/S/    RICHARD L. PETEKA
	Richard L. Peteka Chief Financial Officer (Principal Financial and Accounting Officer)

66